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ABSTRACT 
There has been a rapid increase in the production and useage of nanomaterials during the last 
decade and therefore it is of great importance to properly investigate safety of these materials. 
This thesis specifically focuses on nickel (Ni) and nickel oxide (NiO) nanoparticles (NPs). Ni 
metal particles have been classified by the International Agency for Research on Cancer as 
possibly carcinogenic to humans, Group 2B, while Ni compounds are classified in Group 1 
i.e. carcinogenic to humans. There has been no specific classification for Ni containing 
nanoparticles yet and the risks or mechanisms of carcinogenicity are not fully elucidated. 
Human exposure to Ni containing nanoparticles can occur in occupational settings such as 
through nickel containing dust or through manufacturing of Ni NPs. The overall aim of this 
thesis was to increase the knowledge about the mechanisms underlying the carcinogenicity of 
Ni and Ni compounds as well as to particularly elucidate if Ni in the form of NPs (Ni and 
NiO) act via different mechanisms compared to those of soluble nickel (NiCl2). In study I 
different models were employed to investigate genotoxicity and underlying mechanisms. 
Stronger genotoxic effects were observed for Ni and NiO NPs compared to NiCl2 and 
oxidative stress was identified as an important mechanism for genotoxicity rather than direct 
DNA binding. In general, mutagenic effects were low however a significant increase was 
observed at one concentration of NiO. In study II genotoxicity and the involvement of 
calcium as a possible underlying mechanism was investigated. Chromosomal damage was 
induced by Ni and NiO NPs as well as NiCl2 but cellular uptake was only observed for Ni and 
NiO NPs. A mechanism dependent on calcium and iron was identified for cyto- and 
genotoxicity. In study III inflammation and secondary genotoxicity was investigated by using 
macrophages and lung cells in a co-culture model as well as use of a conditioned media 
approach. Release of inflammatory cytokines from macrophages, exposed to Ni and NiO 
NPs, was found and evidence of secondary genotoxicity was observed. However it is still 
unclear what factors are responsible for these observations. In study IV the ability of Ni and 
NiO NPs as well as NiCl2 to induce markers related to epithelial to mesenchymal transition 
(EMT) and a stem cell like phenotype was studied. Induction of both EMT and stem cell 
markers as well as cellular invasion/migration was found. Little to no differences was 
observed between the Ni and NiO NPs and soluble Ni. In conclusion both primary and 
secondary genotoxicity was observed following exposure to Ni and NiO NPs as well as 
mechanisms related to EMT and a stem cell like phenotype. NiO NPs were most potent in 
generating intracellular ROS and inducing DNA strand breaks. Ni and NiO NPs was shown 
to be taken up by the cells while ionic Ni was not (or limited) which lead to the hypothesis 
that Ni might act via mechanisms related to extracellular factors or interaction with cell 
membranes/receptors. The studies in this thesis have contributed to the knowledge in the field 
of different mechanisms related to carcinogenicity of Ni and NiO NPs.  
 
 
SVENSK SAMMANFATTNING 
Nickel är klassat som cancerframkallande men de underliggande mekanismerna är fortfarande inte 
helt klarlagda. I de flesta studier som hittills utförts har partiklar av nickel (Ni) eller nickel oxid (NiO) 
i mikrometerstorlek eller lösligt nickel studerats. Syftet med den här avhandlingen var att studera 
mindre partiklar, nanopartiklar (NPs), av Ni och NiO med fokus på en rad olika mekanismer som kan 
vara viktiga för utveckling av cancer. Resultaten jämfördes med effekten av lösligt nickel (NiCl2). 
Syftet med studie I var att undersöka genotoxicitet och mutagenicitet av Ni och NiO NPs samt att 
jämföra effekten med lösligt Ni i form av NiCl2. Tre olika modellsystem användes för att undersöka 
detta: 1) exponering av humana bronkepitelceller (HBEC) samt analys av DNA strängbrott (comet 
assay och γ-H2AX-infärgning), 2) Exponering av sex olika embryonala mus-stamceller (mES), så 
kallade ”reporter cell lines” (ToxTracker) som fluorescerar då olika signalvägar av relevans för 
(geno)toxicitet och cancer aktiveras och 3) exponering av mES-celler följt av mutagenicitets-testning 
(Hprt-analys). Resultaten visade på ökning av DNA-strängbrott (comet assay) för NiO NP och vid 
högre doser även för Ni NP, medan inga effekter observerades för Ni joner/komplex från NiCl2. 
Experiment med ToxTracker (reporter cell lines) visade på oxidativ stress som den huvudsakliga 
toxiska mekanismen samt en förändrad konformation hos proteiner (”protein unfolding”) vid 
cytotoxiska doser för alla tre Ni-exponeringarna. Oxidativ stress påvisades även i HBEC-cellerna efter 
NP-exponering. Det blev ingen induktion av rapportörcellerna som indikerar direkt DNA-skada eller 
påverkan på replikationsgaffeln (”stalled replikation forks”) av någon utav alla exponeringar (NiO NP, 
Ni NP och NiCl2). En liten men statistiskt signifikant ökning av Hprt-mutationer observerades för 
NiO, men endast i en enda dos. Slutsatsen är att Ni och NiO NP visar mer uttalade (geno) toxiska 
effekter jämfört med Ni-joner/ komplex. 
Syftet med studie II var att undersöka genotoxicitet av väl-karakteriserade Ni och NiO NPs i humana 
bronk-epitelceller (BEAS-2B) och att finna möjliga mekanismer. NiCl2 användes för att jämföra 
effekterna av Ni-joner med den från NPs. BEAS-2B-celler exponerades för Ni och NiO NP samt 
NiCl2 och upptag och dos i celler undersöktes med transmissionselektronmikroskop (TEM) och ICP-
MS (”inductively coupled plasma mass spectrometry”). Nanopartiklarna karaktäriserades med 
avseende på ytkomposition, agglomerering och nickelfrisättning i cellmedium (ICP-MS). Celldöd 
(nekros/ apoptos) undersöktes genom annexin V/PI-infärgning (flödescytometri) och genotoxicitet 
testades genom analys av mikrokärnor, kromosomabberrationer och DNA stängbrott. Reaktiva 
syremolykyler (”ROS”) och kalcium mättes med fluorescerande prober. Resultaten visade att NPs 
effektivt togs upp av BEAS-2B-cellerna. Däremot observerades inget eller mindre upptag för Ni joner 
från NiCl2. Trots skillnader i upptagning orsakade alla exponeringar (NiO, Ni NP och NiCl2) 
kromosomskador. NiO NPs var mest potent i att orsaka DNA-strängbrott och generera intracellulär 
ROS. En ökning av intracellulärt kalcium observerades och manipulering av intracellulärt kalcium 
med hjälp av inhibitorer och kelatorer minskade kromosomskadorna. Kelering av järn skyddade också 
mot inducerad skada, speciellt för NiO och NiCl2. Slutsatsen är att Ni och NiO NPs samt Ni-joner kan 
inducera kromosomskador och att mekanismen för cyto- och genotoxicitet kan vara kalciumberoende. 
Syftet med stidie III var att undersöka inflammation och genotoxicitet av Ni och NiO NPs samt att 
undersöka möjligheten att testa sekundär (inflammationsdriven) genotoxicitet in vitro. Som en 
kontrollpartikel att jämföra med användes kristallin silika (SiO2) eftersom den partikeltypen har visat 
på cancerframkallande egenskaper som föreslås vara inflammatoriskt drivna. Resultaten påvisade 
frisättning av inflammatoriska mediatorer, så som VEGF, MIF och Flt-3-ligand, då makrofager 
  
(differentierade THP-1 celler) utsattes för partiklarna. Två olika system testades för att undersöka 
inflammationsdriven genotoxicitet. 1) epitelceller (HBEC) utsattes för medium från exponerade THP-
1 celler (”Conditioned media”, CM) och DNA-strängbrott hos HBEC analyserades med 
kometmetoden. 2. Makrofager utsattes för partiklarna då de samodlades tillsammans med HBEC 
celler (enbart makrofagerna var direkt utsatta för partiklarna) och kometmetoden användes därefter för 
att undersöka DNA-strängbrott hos HBEC. I båda fall visade resultaten visade på en ökning av DNA 
strängbrott. Slutsatsen är att Ni och NiO kan orsaka sekundär genotoxicitet och denna effekt kan 
studieras med dessa två testsystem.   
Syftet med studie IV var att undersöka molekylära mekanismer som är relevanta för cancer med fokus 
på ”epitelial to mesenchymal transition” (EMT) och förvärv av en stamcellslik fenotyp. Effekter 
orsakade av Ni i form av NPs (Ni och NiO) jämfördes med Ni-joner (NiCl2). BEAS-2B exponerades 
för NiO NP, Ni NP och NiCl2 i 48 h och förändringar i genuttryck testades (qPCR) liksom 
förändringar i proteinnivåer (In-cell western, flödescytometri och flourescensmikroskopi) av markörer 
relevanta för EMT, stamcellslik fenotyp samt tumörsupresseorgener. Funktionella analyser utfördes 
också för att se om cellerna fick en större benägenhet att migrera (”scratch wound healing assay” och 
”invasion/migration assay”). Resultaten visade att alla Ni-exponeringar ledde till minskat uttryck av 
tumörsuppressorgener, förändringar i markörer förknippade med EMT inklusive minskat uttryck av E-
cadherin, ökad förmåga att migrera samt förändringar kopplade till en stamcellsfenotyp, såsom 
minskat uttryck av celladhesionsmolekylen CD24. Vi drar slutsatsen att Ni och NiO NP orsakar 
förändringar kopplade till EMT men att effekterna inte var nano-specifika effekter då exponering för 
Ni-joner visar likande effekter.  
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1 INTRODUCTION 
The overall aim of this PhD project is to increase the knowledge about the mechanisms 
underlying the carcinogenicity of nickel compounds and particularly to elucidate if nickel 
(Ni) in nanoparticle-form (nickel NP and nickel oxide NP) act via different mechanisms 
compared to soluble nickel (NiCl2). Thus, this thesis includes an introduction to the field of 
cancer, particularly lung cancer, and how various environmental factors increase the risk 
for lung cancer. Furthermore, since most research performed to date is about micron-sized 
Ni compounds as well as soluble Ni, the knowledge about human exposure, carcinogenicity 
and underlying mechanisms of these compounds will be discussed. 
1.1 CANCER 
Cancer is one of the leading causes of mortality and morbidity in the world. In 2018 the 
cancer burden has risen to 9.6 million cancer related deaths and 18.1 million new cases. 
Lung, breast and colorectum are the top three cancer forms when it comes to incidence and 
are ranked among the top five in terms of mortality. Because of its poor prognosis, lung 
cancer accounts for the largest number of deaths, corresponding to 1.8 million which is 
18.4% of the total deaths. The most commonly diagnosed (men 14.5%, women 8.4%) and 
leading cause of cancer death in men (22%), is lung cancer (IARC 2018). New cancer cases 
are expected to rise by 70% in the next couple of decades. There are five leading lifestyle 
factors that causes about a third of the cancer cases; high body mass index, lack of physical 
activity, low fruit and vegetable intake, tobacco use and alcohol use. The most important 
factor is tobacco use which causes around 70% of global lung cancer deaths and 20% of 
global cancer related deaths. Up to 20% of cancer related deaths in low- and middle-income 
countries are because of viral infections such as human papilloma virus, hepatitis B and C. 
More than 60% of the world’s total new annual cases occur in Africa, Asia and Central and 
South America, which account for 70% of the world’s deaths related to cancer (WHO 2016). 
Cancer, malignant tumours or neoplasms, are terms used to describe a large group of diseases 
which can affect any part of the body. Cancer is in short an uncontrolled fast proliferation of 
abnormal cells which can metastasize and spread thought the body to different organs. In 
most cases the cause of death is not the primary tumour but the metastasis (WHO 2016). The 
six hallmarks of cancer proposed in 2000 were; sustaining proliferative signaling, activating 
invasion and metastasis, evading growth suppressors, enabling replicative immortality, 
inducing angiogenesis and resting cell death (Hanahan and Weinberg 2000). In later years 
researchers has come to identify two emerging hallmarks of cancer:  avoiding immune 
destruction  and deregulating cellular energetics as well as two enabling characteristics: 
tumour promoting inflammation and genome instability and mutation (Hanahan and 
Weinberg 2011). The hallmarks of cancer are summarized in figure 1. 
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Figure 1. Hallmarks of cancer (Hanahan and Weinberg 2011). 
  
1.1.1 Lung Cancer 
Lung cancer is divided into two groups; non-small cell carcinoma (NSCC) and small cell 
carcinoma (small cell lung carcinoma, SCLC). NSCC accounts for 80% of the cases and 
SCLC for 20%. SCLC is highly aggressive and is most commonly treated non-surgically 
while NSCC can be managed with a combination of adjuvant therapy and surgery. SCLC is 
caused by smoking in virtually all the cases. NSCC are divided into subgroups which include 
adenocarcinoma 60%, squamous cell carcinoma 20% and large cell carcinoma (Zheng 2016). 
Despite new treatments for the disease the global situation is worse than before. Most lung 
cancers are discovered at a late stage and most patients with lung cancer eventually die from 
it. A big risk factor for lung cancer is the world wide spread addiction to smoking and 
accounts for 80% of the cases in men and 50% in women. The risk of lung cancer increases 
with dose and duration where duration increase the risk more than number of cigarettes 
smoked per day (Mao et al. 2016). 
1.1.2 DNA damage 
DNA is damaged constantly by insults of various environmental factors e.g. ionizing 
radiation or by intracellular factors such as reactive oxygen species (ROS). A signaling 
network that manages DNA damage response including cell cycle checkpoints and DNA 
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repair pathways protects the genome in normal cells. However, cancer are thought to rise up 
from accumulation of genetic alterations that results in survival advantages and growth 
(Broustas and Lieberman 2014). DNA damage can occur in the following forms; single 
strand breaks, double strand breaks, base modifications, base mismatch, DNA-protein 
crosslink, intrastrand crosslink and interstrand crosslink (leading to stalled replication forks). 
The DNA damage response (DDR) can recognize and process, with help of different proteins, 
the different types of DNA damage (Hosoya and Miyagawa 2014). Genomic instability is 
considered as a hallmark of cancer (Hanahan and Weinberg 2011). Downregulation of DDR 
pathways such as the ones that control p53, ataxia telangiectasia and Rad3-related, kinases 
ataxia telangiectasia mutated and ataxia telangiectasia can give rise to genomic instability. 
There are also six DNA repair pathways; nucleotide excision repair, base excision repair, 
homologous recombination repair, DNA mismatch repair, translesion DNA synthesis as well 
as non-homologous end joining. Defects in any of them can also lead to genomic instability 
(Hosoya and Miyagawa 2014). 
1.1.3 Inflammation and Cancer 
The link between cancer and inflammation was first suggested by Rudolf Virchow in 1863. 
He noted leucocytes in neoplastic tissues and stated the hypothesis that this reflected the 
origin of cancer at chronic inflammation sites (Balkwill and Mantovani 2001). Since then, the 
field has progressed and tumour promoting inflammation was included as a cancer hallmark 
in Hanahan and Weinberg (2011) when the list was updated. 
The link between cancer and inflammation can be described by two different pathways: the 
intrinsic and extrinsic pathway. The intrinsic pathway includes genetic alterations as for 
instance activation of oncogenes by mutation, inactivation of tumour suppressor genes, 
chromosomal rearrangement or amplification. Cells that are transformed can create an 
inflammatory tumour microenvironment, by producing inflammatory factors, where there 
was no existing inflammation initially. In the extrinsic pathway, already existing 
inflammation or infection in certain parts of the body, e.g. prostate, colon and pancreas, 
enhance the risk of cancer development. These two pathways can meet and result in 
transcription activation in tumour cells of factors such as signal transducer and activator of 
transcription 3 (STAT3), nuclear factor-κB (NF-κB) and hypoxia-inducible factor 1α 
(HIF1α). The mentioned transcription factors are in charge of production of inflammatory 
factors such as chemokines and cytokines as well as a cyclooxygenase 2 which generates 
production of prostaglandins. This, in turn, leads to the recruitment of leukocytes where the 
same key transcription factors become activated by cytokines, resulting in production of more 
inflammatory mediators and generation of a cancer inflammatory microenvironment 
(Mantovani et al. 2008). 
Inflammation can in itself generate oxidative stress which in turn can cause more 
inflammation (Fernandes et al. 2015). ROS and reactive nitrogen species (RNS) can be 
produced by inflammatory cells which can lead to induction of DNA damage, enhancement 
of mutation rate as well as an increase of genomic instability (Waris and Ahsan 2006). 
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Macrophages can release ROS in a process called respiratory burst in response to both 
microbes (Gwinn and Vallyathan 2006) and particle encounter (Beck-Speier et al. 2005). 
1.1.4 Epithelial to Mesenchymal Transition and Cancer 
Epithelial to Mesenchymal Transition (EMT) is a process where cells with epithelial 
phenotypic properties transform into cells with mesenchymal phenotypic properties including 
loss of cell polarity, loss of cell-cell adhesion and the acquisition of migratory and invasive 
traits. Cells can also undergo mesenchymal to epithelial transition (MET) which is the reverse 
process of EMT (Thiery et al. 2009). EMT occurs in embryonic development, wound healing, 
as well as cancer and are divided into tree subtypes. Type I takes place in gastrulation in 
neural crest cells, produced by the mesoderm and ectoderm, which undergoes MET to 
become epithelial cells in organs. Type II can occur in wound healing and lead to fibrosis 
during persistent inflammation. Type III occurs in cancer where the cancer cells can use part 
of the EMT type II program to migrate and invade distant sites in the body, thereby cause 
metastasis. At the distant site the cancer cells are believed to undergo MET and then start to 
proliferate to grow the metastasis (Scanlon et al. 2013). 
Loss of E-cadherin, which is a key component of adherens junctions, is a critical event that 
causes dissolution of the cell-cell contacts during EMT. Lysosomal degradation of E-cadherin 
and endocytosis can be the initial stages of EMT. Metastatic progression and EMT are often 
associated with reversible E-cadherin downregulation involving either repression by EMT-
inducing transcription factors or hypermethylation of the CDH1 (the E-cadherin gene) 
promoter (May et al. 2011). EMT is also characterized by a decrease in expression of other 
epithelial markers such as Claudins and Occludin as well as an increased expression of 
mesenchymal markers, such as Fibronectin, Vimentin, N-cadherin and also transcription 
factors such as SNAIL, SLUG and Twist (Aroeira et al. 2007), shown in figure 2.  
 
Figure 2. Overview on EMT recreated from (Aroeira et al. 2007). 
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1.1.4.1 EMT and CSC 
Another topic discussed in conjunction with EMT and cancer is stem cell markers. The 
cancer stem cell theory states that tumour progression is driven by a small subpopulation of 
cancer cells namely cancer stem cells (CSCs) even called tumor-initiating cells. These CSCs 
is defined by two characteristics: the ability to self-renew and the ability to regenerate the 
phenotypic heterogeneity of the parental tumor (May et al. 2011). CSCs have been involved 
in initiation and sustentation of growth of primary tumours as well as of metastases (Abraham 
et al. 2005; Al-Hajj et al. 2003; Ginestier et al. 2007; Liu et al. 2007; Sheridan et al. 2006). 
CSCs are also responsible for cancer unlimited growth, generation of different populations of 
cancer cells and chemotherapy resistance (Floor et al. 2011).  
It was found that EMT induction in immortalized human mammary epithelial cells leads to de 
novo expression of stem cell markers and gain of functional stem cell properties such as 
mammosphere formation. EMT in non-tumorigenic, immortalized human mammary 
epithelial cells (HMLEs) was generated and it was found that most mesenchymal like cells 
acquired a CD44high/CD24low expression pattern. Neoplastic mammary stem cells have been 
associated to this phenotype. This finding suggests a link between EMT and cancer stem cells 
(Mani et al. 2008). Another study recently found that CD44high/CD24low cells isolated from 
the oral cancer cell lines express genes related to stem cells, show characteristics of EMT and 
this population could give rise to all other cell types. Typical cancer stem cell phenotypes 
were also confirmed in CD44high/CD24low cells such as migration and invasion, increased 
colony formation and sphere forming ability (Ghuwalewala et al. 2016).  
1.1.5 Environmental Pollution and Lung Cancer 
One environmental risk factor for lung cancer is air pollution which is found in both indoor 
and outdoor air. Examples of sources of outdoor air pollution are cars, industrial waste 
burning and heating systems. Polycyclic aromatic hydrocarbons as well as metals such as Ni, 
arsenic and chromium are carcinogens that are generated from combustion of fossil fuels. 
Indoor air pollution can originate from cooking fumes, and benzene and formaldehyde can be 
formed from home décor and building materials. Another source of indoor exposure can be 
radon which comes from soil and building materials. Radon is probably the second most 
common cause of lung cancer after smoking. Twelve occupational exposure factors have 
been identified by The International Agency for Research on Cancer (IARC) as being 
carcinogenic to human lung: Ni, aluminum production, arsenic, asbestos, bis-chloromethyl 
ether, beryllium, cadmium, hexavalent chromium, coke and coal gasification fumes, 
crystalline silica, radon, and soot. Other risk factors for lung cancer can be radiation as well 
as diet, where intake of more fruits and vegetables has been shown to decrease the risk 
(Malhotra et al. 2016; Mao et al. 2016). About 15-20% of all the lung cancer cases are caused 
by occupational carcinogens and ionization radiation (Didkowska et al. 2016).  
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1.1.6 Nickel and Lung Cancer 
Nickel is a metallic compound existing in various mineral forms and is a naturally occurring 
element. It is the 24th most abundant element found in the crust of earth. It is mainly found in 
soil and sediment, and the physicochemical properties of the soil affects its mobilization 
(Cameron et al. 2011). Inorganic Ni compounds are the ones mainly regarded as 
toxicologically relevant. There are four classes of inorganic Ni species based on analytical 
procedure: soluble, sulfidic, metallic and oxidic Ni. This general classification is widely used 
in studies analyzing Ni particulate matter in air of occupational settings (Schaumloffel 2012).  
Ni metal particles are classified by IARC as possibly carcinogenic, Group 2B, whereas Ni 
compounds e.g. high temperature green NiO, are classified as a human carcinogen via 
inhalation exposure, Group 1Ai  (IARC 1990). A variety of mechanisms are suggested to be 
responsible for Ni induced cancer development, but the molecular mechanisms of Ni 
carcinogenicity are not yet fully elucidated (Schaumloffel 2012). The actual carcinogenic 
species is believed to be ionic Ni (Ni2+) because it can bind to cellular components including 
DNA and nuclear proteins (Shen and Zhang 1994). The binding of Ni ions to DNA is 
considered to be weak but the binding to nuclear proteins, such as protamines and histones, is 
with high affinity (Kasprzak et al. 2003; Oller et al. 1997). It is also suggested that Ni ions 
can inhibit enzymes that are required for the repair of DNA as well as enhance the genotoxic 
effects of X-rays and ultraviolet light (Hartwig et al. 1994). 
The National Toxicology Program (NTP) performed long time inhalation exposure studies in 
mice and rats during 2 years. The rats were exposed to 0, 0.62, 1.25, or 2.5 mg NiO/m3 and 
mice were exposed to 0, 1.25, 2.5, or 5 mg NiO/m3 by inhalation for 6 h/day, 5 days/week for 
104 weeks. The outcome in male and female rats was: some evidence of carcinogenic activity 
of NiO. This was based on increased incidences of combined alveolar/bronchiolar adenoma 
or carcinoma and increased incidences of combined benign or malignant pheochromocytoma 
of the adrenal medulla. For the mice the results were: equivocal evidence of carcinogenic 
activity of NiO in the female mice and in the male mice there were no evidence. In the female 
mice this was based on marginally increased incidences of alveolar/bronchiolar adenoma in 
2.5 mg/m3 and of alveolar/bronchiolar adenoma or carcinoma (combined) in 1.25 mg/ m3 
(National Toxicology 1996). 
1.1.6.1 Nickel and Mutagenicity 
The mutagenic potential of Ni compounds is generally considered to be low, despite several 
reports of the chromatin- and DNA damage found in cells and tissues exposed to Ni. The 
results that lead to this conclusion come from mutagenesis assays performed in fruit fly, 
bacteria and mammalian cells (Biggart and Costa 1986; Fletcher et al. 1994; Kargacin et al. 
1993; Lee et al. 1995; Rodriguez-Arnaiz and Ramos 1986). Nevertheless, there are data that 
suggest that Ni could be a potent co-mutagen with alkylating mutagens in some S 
typhimurium and E. coli tester strains (Dubins and LaVelle 1986).  
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Parental exposure to certain metals can increase the risk of cancer in the progeny, according 
to epidemiological studies. Exposure to Ni is suspected to cause pro-mutagenic damage to 
sperm DNA (Cameron et al. 2011). One study showed that Ni(II) could mechanistically be 
involved in reproductive toxicity and carcinogenicity of metals (Liang et al. 1999). Another 
study showed that exposure to Ni chloride in male mice resulted in a transient amount of Ni2+ 
in the testes as well as chromosomal aberrations and reduced sperm count (Cameron et al. 
2011). 
A previous study demonstrated that NiCl2 and black NiO did not induce mutations in V79-
cells but G12 (a transgenic cell line) showed a strong response to the insoluble Ni compounds 
(NiO, NiS and Ni3S2) in  the HPRT-mutation assay (Kargacin et al. 1993). The G10 
transgenic cell line also showed a strong response in regards to mutations after exposure to 
NiO, NiS and Ni3S2. NiCl2 were also potent in inducing mutations but to a lesser extent (Klein 
et al. 1994).  
1.1.6.2 Epigenetic mechanisms 
Gene expression is not only determined by base sequence of DNA, but also depends on 
dynamic states of the chromatin. DNA methylation and histone posttranslational 
modifications are the two main groups of epigenetic mechanisms that affects gene expression 
at the chromatin level (Arita and Costa 2009). The best understood and most common 
epigenetic modification in DNA is methylation. The molecular process of DNA methylation 
is when a methyl group is added to the 5′ position of the cytosine ring on a CpG dinucleotide 
to create 5-methylcytosine (Miller et al. 1974). Methylation of the promoter region can be 
used to turn on and off gene transcription and methylation of a gene promoter in general leads 
to repression of transcription (Jones 1999).  
Changes in DNA methylation leading to gene expression inactivation after Ni exposure was 
initially found in the Chinese hamster G12 cell line. This cell line possesses a copy of the 
bacterial gpt transgene near the telomere of chromosome 1 (Lee et al. 1995). An in vivo study 
showed changes in DNA methylation after exposure to Ni sulfide and tumours were induced. 
Hypermethylation of the promoter of gene p16, which is a tumour suppressor gene, was 
found in all tumours in the mice (Govindarajan et al. 2002). Another study showed a 
correlation between Ni urinary levels and DNA methylation in the promoter of the tumor 
suppressor gene p15 in Ni exposed workers (Yang et al. 2014). 
1.1.6.3 Particles vs Ions: Ni bioavailable theory 
The so-called “nickel ion theory” states that Ni of all forms could lead to an increased risk of 
lung cancer, with the following order lowest to highest risk: water-soluble Ni, metallic and 
sulfidic Ni, and last oxidic Ni. The nickel ion bioavailability model is refined from the nickel 
ion theory. This model states that: “the presence of nickel ions in a substance is not sufficient 
for that substance to be a complete carcinogen”. To act as a carcinogen, Ni ions that become 
bioavailable at the nucleus of epithelial lung cells must be released from the substance. It 
must also reach the cell in sufficient amounts and the cell has to survive in order for the 
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substance to cause carcinogenesis. The degree of bioavailability will decide the carcinogenic 
potency of the Ni ion releasing substance. Interaction of many different factors influences the 
Ni ion bioavailability at epithelial cell nuclear sites. Such factors can be; target cell uptake, 
clearance, intracellular dissolution and respiratory toxicity, which also differ between 
different forms of Ni. This could mean that there is a threshold for Ni initiated 
carcinogenesis. For some compounds a “practical” threshold for carcinogenesis is likely such 
as weakly genotoxic substances. For compounds like these, secondary mechanisms of 
carcinogenesis could be of importance. Workers exposed to sulfidic and oxidic Ni 
compounds have an increased incidence of lung cancer, but this does not apply for workers 
exposed to metallic Ni or water soluble Ni compounds alone, which is evidence that supports 
the nickel ion bioavailability model (Goodman et al. 2011). 
1.1.6.4 Nickel and EMT 
Only a few studies have been performed regarding Ni and EMT to this date. One study 
showed that NiCl2 and NiSO4 can induce expression of EMT markers and E-cadherin 
promoter hypermethylation through ROS generation. Both NiCl2 and NiSO4 were shown to 
reduce expression of E-cadherin in BEAS-2B cells. NiCl2 were also shown to decrease E-
cadherin in lung cancer cell lines. Longer exposure (6 or 9 days) to a lower dose of NiCl2 was 
shown to decrease E-cadherin and increase fibronectin expression. Upregulation of Hif1α 
was observed after NiCl2 exposure. Transcription factors SNAIL, SLUG and HiF1a was 
shown to bind to the E-cadherin promoter after exposure to NiCl2. The suggested mechanism 
for EMT in this study was via ROS and exposure to NiCl2 can lead to epigenetic changes in 
the E-cadherin promoter (Wu et al. 2012). 
Another study showed that exposure to NiCl2 induced a persistent mesenchymal phenotype in 
BEAS-2B cells through epigenetic activation of ZEB1. Transcriptional changes persisted 
even after the exposure was removed and depletion of ZEB1 resulted in attenuation of EMT 
in exposed cells. Both acute (72 h) and long term (6 weeks) exposure was performed. 
Decrease in E-cadherin and Claudin 1 as well as increase in fibronectin expression was 
observed after acute exposure. E-cadherin levels were also decreased after long term 
exposure in BEAS-2B as well as in the RT4 cancer cell line. Increased invasive ability was 
also observed in BEAS-2B and RT4 cells after long term exposure (Jose et al. 2018). 
Another study showed that exposure to NiCl2 (1 mM 48 h) down regulated E-cadherin and 
Claudin7 and strongly upregulated Snai2 but not Snai1. The same study also found that 
SFMBT1 (belongs to the malignant brain tumor (MBT) domain-containing protein family 
that is critical in chromatin regulation) is essential for the induction of EMT by NiCl2 (Tang 
et al. 2013). 
1.1.6.5 Nickel Exposure in Humans 
Exposure of metals to humans is common due to the wide usage in industries and also the 
persistence of metals in the environment. Ni industries, trash incinerators, oil and coal 
burning power plants have been contributing to release into the environment. Ni existing in 
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the atmosphere is removed from air by rain or snow alternatively by attaching to small dust 
particles which further settle to the ground. Ni that sediment or is released from industrial 
wastewater into the soil can bind to manganese or iron particles. Ni is primarily used in 
stainless steel production as an alloy and this usage accounts for 80% of the Ni use. It can 
also be used in battery production and plating which accounts for 10% of the usage. Around 
5% of the primary Ni is used in printing inks and applications of foundary. Different factors 
such as dose, route of exposure, and solubility of the Ni compound influences the toxicity. 
The major route for exposure to toxicity induced by Ni is lung inhalation. Ni can also be 
absorbed through the skin or ingested, and the primary target organs are the lungs and 
kidneys. Other organs that can be affected, but to a lesser extent, are; spleen, liver, heart and 
testes (Cameron et al. 2011). 
Humans are exposed to Ni via ambient air, food consumption, drinking water or by smoking 
tobacco. Intake via food and drinking water stands for the highest intake of Ni and Ni 
compounds in the general population (Schaumloffel 2012). Other sources of exposure can be 
via skin absorption caused by direct skin contact from jewelry and coins. Another exposure 
could be from artificial body parts such as endoprostheses, bone-fixing plates and screws, 
where Ni containing alloys are used (Kasprzak et al. 2003; Schaumloffel 2012). 
Non-smokers inhale about 0.1-1 μg Ni per day. Smoking of cigarettes increases exposure to 
Ni by 0.4 microgram per day. Inhalation of Ni is the primary source of exposure for workers 
in the Ni industries. Occupationally exposed individuals have higher levels of Ni than the 
general population. The Ni amount which is likely inhaled by the general population ranges 
from 0.1-0.25 mg Ni per day, while 0.3 to 0.8 mg Ni per day in Ni refining operations are 
likely to be inhaled. Depending on the industry, the amount of inhalation ranges from < 0.02 
to 1.0 mg Ni per day (Cameron et al. 2011). About 2% of the workers in industries related to 
Ni are exposed to concentrations of airborne Ni containing particles in the range of 0.1 to 
1 mg/m3 (Kasprzak et al. 2003). For powder metallurgy operations the average airborne Ni 
concentrations have been reported to exceed 1.0 mg/m3 (Cameron et al. 2011). 
1.2 NANOPARTICLES 
Nanomaterials can be described as materials “with any external dimension in the nanoscale or 
having internal structure or surface structure in the nanoscale”, where the nanoscale most 
often is considered to be between 1-100 nm. Nanomaterials are used for a vast number of 
purposes in the industry today, for instance in tires, stain-resistant clothing, sporting goods, 
cosmetics, sunscreens, and electronics. The usage is also increasing in medical applications 
like imaging, diagnosis, and drug delivery (Nel et al. 2006). The number of products 
containing nanomaterials is to this day approximately 3000 according to the Danish database 
(nanodb.dk 2018). 
Nanoparticles (NPs) are often characterized as a material that has one or more dimensions 
between 1-100 nm. However this definition has been debated but in 2011 EU recommended 
the following definition of a nanomaterial: “A natural, incidental or manufactured material 
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containing particles, in an unbound state or as an aggregate or as an agglomerate and 
where, for 50 % or more of the particles in the number size distribution, one or more external 
dimensions is in the size range 1 nm - 100 nm” (2011/696/EU 2011). 
NPs hold specific properties, compared to their non nano sized equivalent, and can induce 
nano specific toxic effects. They harbor unusual properties due to their size, chemical 
composition and shape. The small size of NPs can be similar to biological molecules, for 
instance viruses or proteins, which allows them to enter tissues, cells and organelles. In 
nanotoxicology the dose is of course important, but the size is also crucial because it affects 
the surface to mass ratio, which in turn has an impact on surface reactivity and chemistry  
(Fadeel and Garcia-Bennett 2010). NPs can travel through the body, deposit in target organs, 
penetrate cell membranes, lodge in mitochondria and trigger injurious responses (Nel et al. 
2006). 
Exposure to NPs can occur through inhalation, ingestion or skin contact. Due to their small 
size, penetration and deposition of NPs can occur deeper in the alveolar region in the lungs as 
compared to larger particles. Information about NP lung deposition is important in order to 
estimate the dose received by the organism after inhalation. Diffusion is the main mechanism 
for deposition after inhalation of NPs and occurs due to collision of the NPs with air 
molecules. Mechanisms that apply for larger particles do not apply for NPs except for 
electrostatic precipitation which only occurs when NPs harbor electric charge (Oberdorster et 
al. 2005). Based on a model by the International Commission on Radiological Protection 
(ICRP 1994) particles of different size deposits differently in the nasopharyngeal, 
tracheobronchial and alveolar region of the respiratory tract. For instance, the model predicts 
that 90% of 1 nm NPs deposits in the nasopharyngeal part, 10% in the tracheobronchial part 
while almost none in the alveolar part. The prediction for 5 nm NP deposition was more or 
less an equal distribution in all three parts. The 20 nm NPs was predicted to deposit around 
50% in the alveolar part and 15% in the other two parts, respectively (figure 3). After 
deposition, the NPs can translocate to extrapulmonary sites and end up in other organs via 
different routes such as: transcytosis through epithelial cells into the interstitium, and hence 
get access to the blood stream directly, or via the lymphatic system. Another, not generally 
recognized, route is via sensory nerve endings which are embedded in airway epithelia and 
thereafter axonal translocation to CNS and ganglionic structures (Oberdorster et al. 2005). It 
has been observed that particles can take a paracellular route between the cells by disrupting 
the tight junctions themselves or if some other agent cause them to disrupt and thereafter 
enter the blood stream (Puisney et al. 2018). It has also been shown that particles can 
translocate from the nose via the olfactory bulb to the brain (Oberdorster et al. 2004). 
  11 
 
Figure 3. Fractional deposition of inhaled particles in the human respiratory tract. From (Oberdorster et al. 2005) 
with corrected modifications. (Permission received from Günter Oberdörster.) 
Clearance of particles in the respiratory tract can occur either via chemical clearance or 
physical translocation of particles by different processes. The physical clearance processes 
are different for each of the tree regions of the respiratory tract and include; mucociliary 
movement, macrophage phagocytosis, epithelial endocytosis, interstitial translocation, 
lymphatic drainage, blood circulation and sensory neurons. The chemical clearance processes 
are: dissolution, leaching and protein binding, and they can occur in any of the three region 
(Oberdorster et al. 2005). 
An important aspect of NPs is the so called “transport principle” (Krug and Wick 2011) or 
the “Trojan horse effect”. Metal ions are normally transported across the cell membrane and 
this process is well-regulated, but when the metal comes in contact with the cell in NP form 
this regulation is circumvented via several endocytotic mechanisms. When the particles have 
entered the cell, they may undergo dissolution within acidic cell compartments, this occurs in 
regard to many metal and metal oxide NPs. In other words, the particle structure in the form 
of a NP acts as a Trojan horse which sneaks into the cells and once inside releases ions, 
which results in toxic events (Cronholm et al. 2013; Stark 2011). 
An important property that particles harbor is the inverse relationship between size of the 
particle and the number of expressed molecules on the surface. When the size of a particle 
decreases, the surface area further increases, hence displaying more surface atoms which in 
turn makes them more reactive. Engineering of nanomaterials can change physicochemical 
and structural properties; for instance, a decrease in size can lead to a number of material 
interactions which in turn leads to toxicological effects. The impact of these changes depends 
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on the composition of the material, for instance surface groups can change the nanomaterial 
from hydrophobic to hydrophilic or lipophilic to lipophobic. Interaction of electron acceptor 
or donor active sites (physically or chemically activated) with molecular dioxygen (O2) is an 
example of surface properties that can lead to toxic events. If an electron is stolen from the 
dioxygen molecule the formation of free radicals will occur, namely the superoxide radical 
(O2.–), which will generate ROS. This can occur in both single component material and also 
in the presence of transition metals on the surface of engineered nanomaterials e.g., Fe and 
vanadium. The best developed paradigm for toxicity of NPs is ROS generation. Other 
properties could also affect physicochemical and transport properties and possibly amplify 
size effects such as shape, surface coating, aggregation, and solubility (Nel et al. 2006). 
1.2.1 Studying Toxicity of Nanoparticles 
An important aspect of nano toxicology is proper characterization of the nanomaterial. This is 
important to be able to correlate the particle characteristics with the measured toxicological or 
biological outcome as well as setting a reference point to be able to compare the results with 
other studies. The properties that dictate the uniqueness of the material are chemical 
composition, size and shape as well as possible coating. There are three phases of particle 
characterization; primary in their dry state, secondary when particles are in solution or 
suspended in liquid and tertiary which is performed when the particles are in interaction with 
cells in vitro or in vivo. Preferably characterizations needs to be performed using more than 
one technique (Sayes and Warheit 2009).  
Another important aspect is the dosimetry, meaning the accurate measure of the dose or the 
amount of, in this case, particles that comes in contact with the target. Different dose metrics 
have been used within nano toxicology including: µg/ml, cm2/ml, µg/cm2 and particle 
number/ml. There have been further statements that the nominal dose might not be the 
accurate dose that is delivered to the cells, or the intracellular dose (Lison et al. 2014). To 
estimate the delivered dose mathematical models can be used as a tool. For instance the ISDD 
(In vitro Sedimentation, Diffusion and Dosimetry) model can be used to make predictions 
about the power of in vitro systems and improve accuracy which will make it easier to design 
studies that better relate to human exposure (Hinderliter et al. 2010). However, the 
intracellular dose is not always relevant as some types of NPs might act extracellularly by for 
instance release of ions. Uptake should also be considered as different cells in different states 
might take up particles differently (Lison et al. 2014). Another problem is that some studies 
use exaggerated doses that are too high to be of relevance in a realistic exposure scenario in 
humans. This could be the result of the desire to publish positive results. Hence it is important 
to consider relevant doses both in vivo and in vitro (Krug and Wick 2011).  
Another issue is that some NPs can harbor some intrinsic properties which can interfere with 
classical toxicological assays and possibly interfere with the results. Some examples are; 
interferance with MTS cell viability assay (Doak et al. 2009), quenching of florescent dyes 
(Sabatini et al. 2007), quenching of DCF fluorescence (Pfaller et al. 2010), changing the color 
and increase the opalescence of experimental resin matrices (Yu et al. 2009), absorption and 
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scattering UV radiation as well as visible light (Wolf et al. 2001). NPs have also been shown 
to interfere with the comet assay by inducing additional breaks in the naked DNA during 
assay performance, induction of additional breaks from photocatalytic NPs in the nucleoid 
during performance of the assay, interference with scoring and interference with nucleoid 
DNA during electrophoresis (Karlsson et al. 2015). 
1.2.2 Nanoparticles, Genotoxicity and Cancer 
NPs can induce genotoxicity via primary (direct or indirect) or secondary mechanisms (Evans 
et al. 2017). Direct primary genotoxicity requires direct interaction of NPs with DNA or 
chromosomes potentially causing DNA lesions, mutagenesis, physical strand breakages or 
frameshift mutations (Schins and Knaapen 2007). During indirect primary genotoxicity the 
NPs does not interact directly with DNA but causes DNA damage through other molecules or 
mechanisms. The damage can be due to interactions with DNA repair proteins, disturbing cell 
cycle checkpoints, interactions with antioxidants and ROS generation (Magdolenova et al. 
2014). There are tree general mechanisms in regards to oxidative stress: (i) Particles can by 
themselves generate oxidants which can cause DNA-damage. This will depend on the 
chemical and physical properties of different particles. Highly reactive hydroxyl radicals 
(OH•) can be created from transition metals via Fenton type reactions, for instance. (ii) Target 
cells can be stimulated by particles and produce genotoxic compounds or oxidants, which can 
induce cytochrome P450 enzymes or affect mitochondrial electron transport. (iii) Particles 
can cause inflammation where the inflammatory cells can produce oxidants (secondary 
genotoxicity) (Knaapen et al. 2004).  
Secondary genotoxicity is caused by recruited immune cells such as macrophages and 
neutrophils, as a result of inflammation. These immune cells are recruited to clear the tissue 
from foreign particles which can result in an event known as oxidative burst where ROS is 
released (Evans et al. 2017). Cytokines and chemokines activate and recruits immune cells to 
sites of inflammation and are involved in the progression of inflammatory events (Feghali 
and Wright 1997). Generation of ROS can trigger release of pro-inflammatory cytokines via 
activation of redox sensitive signaling pathways such as MAPK and NF-κB which are in 
control of transcription of inflammatory genes e.g. IL-1β, IL-8, and TNF-α (Thannickal and 
Fanburg 2000). An overview of primary and secondary genotoxicity mechanisms are shown 
in figure 4. 
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Figure 4. Overview of genotoxicity mechanisms induced by NPs. 
Another mechanism that is discussed is that fact that NPs can be transported to the nucleus 
and hence be given direct access to the DNA. However this seems rather unlikely because the 
diameter of the nuclear pore complex is less than 8 nm (Terry et al. 2007). However, a few 
studies have found NPs in the nucleus, for instance titania (21 nm) and iron oxide (8.1 and 
31.8 nm) NPs (Ahlinder et al. 2013), silver NPs (6-20 nm) (AshaRani et al. 2009) and silica 
NPs (40-70 nm) (Chen and von Mikecz 2005). A hypothesis for this phenomenon is that 
when the nuclear membrane breaks down during mitosis, particles may come in contact with 
DNA and this can lead to direct interactions. A consequence of this could be mechanical 
interference with the microtubules which could give rise to aneuploid cells during mitosis 
(Gonzalez et al. 2008). Intracellular metal ions from particles or particles themselves could 
also enhance the permeability of the lysosomal membrane. This can lead to DNase release 
into the cytoplasm where it could possibly pass into the nucleus and cut the DNA (Banasik et 
al. 2005).  
1.3 NICKEL AND NICKEL OXIDE NANOPARTICLES 
Ni NPs have unique characteristics that are only present at nano scale which includes high 
magnetism, a high level of surface energy, large surface area, low melting point, high and low 
burning point. Unfortunately, the same characteristics, in combination with their small size, 
cause the Ni NPs to pose a threat to human health. Studies have previously been conducted 
regarding Ni and genotoxicity. Common methods used have been micronucleus test, comet 
assay, Ames test and mammalian cell mutagenicity assays. However, the amounts of studies 
about Ni NPs and genotoxicity are still scarce, and most studies have been focusing on 
cytotoxicity. Non-genetic factors that may cause carcinogenicity that have been studied 
before in conjunction with Ni NPs are; enhanced oxidative stress, inflammatory response and 
abnormal apoptosis (Magaye and Zhao 2012). 
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1.3.1 Nickel Nanoparticles 
A selection of studies regarding Ni NPs, of interest to the author, is presented in table 1.  
Table 1. A selection of in vitro and in vivo involving Ni NPs. 
Size (nm) 
Concentration 
Time 
Organism 
Results   Reference 
100 
5, 10, 50, 100, and 200 
μg/ml 
24 h 
A549 
Induction of higher levels of apoptosis than TiO2 and silica 
fine particles. They also show that there was an increase in 
DNA fragmentation, about 20-24% and they hypothesize 
that these effects were due to generation of ROS. 
(Park et al. 2007). 
52.10 ± 6.40 
2, 4, 8 & 20  μg/ml 
24 & 48 h 
A431 cells 
Cytotoxicity in a dose- and time-dependent manner. 
Oxidative stress evidenced by the generation of ROS and 
depletion of GSH. Dose- and time-dependent genotoxicity. 
Oxidative stress resulting in apoptosis and genotoxicity. 
(Alarifi et al. 
2014) 
28  
10, 25, and 50 μg/ml 
24 h 
MCF-7 cells 
Dose-dependent decreased cell viability and damaged cell 
membrane integrity. Oxidative stress induced in a dose-
dependent manner. Dose-dependent induction of DNA 
damage. The level of mRNA and activity of caspase-3 
enzyme was increased. 
(Ahamed and 
Alhadlaq 2014) 
<100 
0-20 μg/cm2 
24, 48 & 72 h 
H460 cells 
Dose-dependent and time-dependent toxicity, observed by 
reduced cell number. Ni NPs induced cleavage of caspase-3, 
caspase-7, and PARP in H460 cells within 48-72 h of 
exposure, indicating apoptosis. 
(Pietruska et al. 
2011) 
<100 
0.1, 1, 5, 10, 20 and 40 
μg/cm2 
4, 24 and 48 h 
A549 cells 
Increased cytotoxicity in the highest doses (20-40 μg cm2). 
Increased CFE, suggesting higher proliferation, in low doses 
(0.1 or 1 μg cm2).  
(Latvala et al. 
2016) 
92.32 ± 29.69 
0.5-20 μg/cm2 
1, 3, 6, 8 & 24 h 
JB6 cells 
Higher AP-1 and NF-κB activation and a larger decrease of 
p53 transcription activity than fine particles. Induction of a 
higher protein level expressions for R-Ras, c-myc, C-Jun, 
p65, and p50 in a time-dependent manner. Increase 
anchorage-independent colony formation.  
(Magaye et al. 
2014a) 
92.32 ± 29.69 
0-20 μg/cm2 
1, 3, 6, 8 & 24 h 
JB6 cells 
Induction of higher cytotoxicity and apoptosis than fine 
particles in JB6 cells. Apoptotic cell death through a 
caspase-8/AIF mediated cytochrome c-independent 
pathway. 
(Zhao et al. 2009) 
40.50 ± 18.6 
0, 2.5, 5, 7.5 & 10 μg/cm2 
24 h 
JB6 cells 
Dose-dependent cytotoxicity. EGCG caused a certain 
inhibition on toxicity. EGCG reduced apoptotic cell number 
and ROS. EGCG downregulated Ni NPs-induced activation 
of activator protein-1 and NF-κB. EGCG eased toxicity of 
Ni NPs through regulation of protein changes in MAPK 
signaling pathways. 
(Gu et al. 2016) 
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62 
0.5, 5, and 50 ug/ml 
24 h 
HDMEC 
Dose-dependent cytotoxicity. Difference in effects on 
oxidative stress and pro-inflammatory response. Different 
effects were observed when comparing to ions as well as 
indication of differences in the signaling pathways.  
(Peters et al. 2007) 
50 
1 mg/kg, 10 mg/kg, and 20 
mg/kg, intravenous 
injection 
15 days 
Rat 
Acute inflammation in lung, shown by lymphocytic 
infiltration in all dose groups and foamy macrophages in the 
high dose group. A high percentage of monocytes in the 
blood. Intravenous injection of Ni NPs may impact the liver, 
lung, spleen, and heart. 
(Magaye et al. 
2014b) 
5 (Ni(OH)2) NPs 
500 μg/m3 
5 h 
Mice 
Acute inhalation exposure significantly increased both bone 
marrow EPCs and their levels in circulation. Indication of 
endothelial damage due to exposure. Tube formation and 
chemotaxis, but not proliferation, of bone marrow EPCs was 
afflicted. Decrease in mRNA of receptors involved in 
homing and mobilization of EPC. 
(Liberda et al. 
2014) 
40.50 ± 18.6  
0, 1, 5, 10, 15 and 
25 µg/cm2, cells 
5.6, 12 and 25 mg/kg, 
intratracheal instllation 
A549 & Rat 
Higher potency in cell toxicity and genotoxicity in vitro 
compared to Ni FPs. Ni NPs and FPs induced toxicity in 
organs of the SD rats and effects were similar for both 
particle types. 
(Magaye et al. 
2016) 
 
In addition two case reports were found. A 38 year old healthy male was exposed to Ni by 
inhalation using a metal arc process while spraying Ni onto bushes for turbine bearings. He 
passed away 13 days later and adult respiratory distress syndrome was determined as the 
cause of death. The presence of Ni NPs where found in the lung but only in macrophages. 
The diameter of the NPs produced by the Ni metal arc process was on average about 50 nm 
while the particles in the macrophages were 25 nm or less in diameter. The particles appeared 
to exist in the lysosomes and could not be observed in other lung cells (Phillips et al. 2010). A 
female, 26 years old worked with Ni NP powder. The task included weighing out and 
handling on a lab bench without protective equipment. She developed nasal congestion, 
throat irritation, facial flushing, "post nasal drip" and new skin reactions to her belt buckle 
and earrings, which were temporally related to working with the NPs. She had a positive 
reaction to Ni on the T.R.U.E. patch test, and a normal range forced expiratory volume in one 
second that increased by 16% post bronchodilator. It was difficult for her to return to work, 
even in other parts of the building, because the symptoms reoccurred (Journeay and Goldman 
2014). 
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1.3.2 Nickel Oxide Nanoparticles 
 
A selection of studies regarding NiO NPs, of interest to the author, is presented in table 2.  
Table 2. A selection of in vitro and in vivo involving NiO NPs. 
Size (nm) 
Concentration 
Time 
Organism 
Results   Reference 
44 
2-100 μg/mL 
24 h 
HepG2 cells 
Cytotoxicity (cell death) and dose dependent ROS. Vitamin 
C reduced cell death indicating that oxidative stress plays an 
important role. Micronuclei induction, chromatin 
condensation and DNA damage. Cell death could be 
induced via an apoptotic pathway. 
(Ahamed et al. 
2013) 
15-24  
25, 50 and 100 μg/mL 
24 h 
HepG2 cells 
Oxidative stress, DNA damage, apoptosis and transcriptome 
alterations 
(Saquib et al. 
2018) 
15.0  ± 4.2-38.1 
range of 0-500 μg/mL 
24 h 
SH-SY5Y cells 
Uptake in dose dependent manner. Morphological changes, 
dose-dependent DNA damage, apoptosis, oxidative damage. 
(Abudayyak et al. 
2017a) 
4.2-38.1 
0-500 μg/mL 
24 h 
NRK-52E cells 
Dose-dependent DNA damage and oxidative damage 
increasing levels of MDA, 8-OHdG, PC and depletion of 
GSH. Apoptotic/necrotic effects and morphological 
changes. 
(Abudayyak et al. 
2017b) 
<50 
0.1, 1, 5, 10, 20 and 40 μg 
cm-2 
4, 24 and 48 h 
A549 cells 
Increased cytotoxicity in the highest doses. Increased CFE, 
suggesting higher proliferation, in low doses 0.1 or 1 μg 
cm2. ROS and DNA damage. 
(Latvala et al. 
2016) 
<50 
5, 10, and 20 μg/cm2 
24 and 48 h 
BEAS-2B cells 
Uptake by the cells and release of Ni2 +. Cytotoxicity by 
apoptosis. Repressed SIRT1 expression and activated p53 
and Bax. Overexpression of SIRT1 attenuated NiO NPs-
induced apoptosis via deacetylation p53. 
(Duan et al. 2015) 
22 
1-100 μg/ml 
24 h 
HEp-2 & MCF-7 cells 
Cell viability was dose-dependent reduced. Induction of 
dose-dependent oxidative stress by depletion of glutathione, 
induction of ROS and lipid peroxidation. Induction of 
caspase-3 enzyme activity and DNA fragmentation, 
biomarkers of apoptosis. 
(Siddiqui et al. 
2012) 
<100 
0-20 μg/cm2 
24, 48 & 72 h 
H460 cells 
Dose-dependent and time-dependent toxicity by reduced 
cell number. NiO NPs induced cleavage of caspase-3, 
caspase-7 and PARP which indicates apoptosis. 
(Pietruska et al. 
2011) 
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20  
0.015, 0.06, and 0.24 
mg/kg, intratracheal 
instillation 
6 w 
Rat 
TGF-β1 content was increased. Upregulation of gene 
expression of TGF-β1, Smad2, Smad4, matrix 
metalloproteinase, and tissue inhibitor of metalloproteinase. 
Induction of pulmonary fibrosis, which may be related to 
activation of TGF-β1. 
(Chang et al. 
2017b) 
19  
0.2 and 1.0 mg, 
intratracheal instillation  
0.32 and 1.65 mg/m³, 
inhalation 
4 w 
Rat 
NPs persisted for longer in the lung and biological half 
times was longer compared with TiO2 NPs. Biopersistence 
correlated with inflammatory response, histopathological 
changes, and other biomarkers in BALF. 
(Oyabu et al. 
2017) 
15-35 
0.2 mg or 1.0 mg, 
intratracheal instillation 
1.65 ± 0.20 mg/m3 and 
0.32 ± 0.07 mg/m3, 
inhalation 
4 w 
Rat 
Pulmonary oxidative stress was induced by both 
administration methods. Single intratracheal instillation 
induced major pulmonary oxidative stress while inhalation 
induced milder and continuous oxidative stress. 
(Horie et al. 2016) 
30 and 100  
0.2 mg (0.8 mg/kg) or 1 mg 
(4 mg/kg), intratracheal 
instillation 
1.65 ± 0.20 mg/m3, 
inhalation 
4 w 
Rat 
The inhalation of NiO induced neutrophil inflammation and 
related cytokine upregulation. The intratracheal instillation 
of NiO induced persistent and transient inflammation and 
upregulation of cytokines. 
(Morimoto et al. 
2016) 
<50 
1, 2, 4 mg/kg b.w/day, 
orally 
1 & 2 w 
Rat 
Increase in chromosomal aberrations, formation of 
micronuclei and DNA damage. Apoptosis, generation of 
ROS and dysfunction of mitochondrial membrane potential. 
Imbalance of antioxidant enzymes and histological 
alterations was observed in the liver. 
(Saquib et al. 
2017) 
15.62 ± 2.59 
125, 250 and 500 mg/kg 
bw, orally 
18 & 24 h 
Rat 
DNA damage and chromosomal changes at 500 mg/kg bw 
dose in the PBL, liver and kidney cells. Hepatic damage and 
mild alterations in kidneys. 
(Dumala et al. 
2017) 
20 
2 mg/kg bw, intratracheal 
instllation 
3, 28 & 91 days 
Rat 
BALF analyses revealed pulmonary injury, inflammation. 
Histopathological analyses demonstrated inflammatory 
response, phagocytosis of NiO by alveolar macrophages, 
degeneration and necrosis of alveolar macrophages. 
(Senoh et al. 2017) 
20 
0.015, 0.06, and 0.24 
mg/kg, intratracheal 
instllation 
6 w 
Rat 
Pulmonary fibrosis was induced and could be related to 
TGF-β1 activation. TGF-β1 content was increased, and 
upregulation in expression of the genes TGF-β1, Smad2, 
Smad4, matrix metalloproteinase and tissue inhibitor of 
metalloproteinase. 
(Chang et al. 
2017b) 
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18.6 ± 5.5 
3.3 mg/kg, intratracheal 
instllation 
3,7 & 28 days 
Rat & RAW264.7 cells 
NLRP3 was upregulated, overexpression of active form of 
caspase-1 (p20) and IL-1β secretion in vivo. siRNA-
mediated NLRP3 knockdown completely attenuated NiO 
NP induced cytokine release and caspase-1 activity in 
macrophages in vitro. Induction of NLRP3 inflammasome 
activation requires particle uptake and ROS production. 
(Cao et al. 2016) 
∼20 
0.015, 0.06, and 0.24 
mg/ kg, intratracheal 
instllation 
6 w 
Rat 
Abnormal changes on indicators of nitrative stress, 
inflammatory cytokines and cytokine-induced neutrophil 
chemoattractants in lung tissue. Upregulated mRNA and 
protein expression of NF-κB, inhibitor of κB kinase-α and 
nuclear factor-inducing kinase.  
(Chang et al. 
2017a) 
- 
0. 015, 0. 06 and 0. 24 
mg/kg 
6 w 
Rat 
Histopathology showed that the widened alveolar speta, 
inflammatory infiltration and NP deposition increased with 
the increasing dosage. Higher levels of IL-2, TGF-β and 
IFN-γ. Level of 8-OHd G increased in serum. 
(Liu et al. 2016) 
<50 
800 μg/rat, intratracheal 
instllation 
28 & 60 days 
Rat & human fetal lung 
fibroblasts 
Pulmonary fibrosis in vivo and in vitro. TGF-β1 facilitated 
HIF-1α signaling by accumulating HIF-1α protein and 
enhancing DNA binding activity of HIF-1α. Activated HIF-
1α promoted TGF-β1 expression in mRNA and protein 
level. 
(Qian et al. 2015) 
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2 AIM 
The overall aim of this thesis is to increase the knowledge about the mechanisms underlying 
the carcinogenicity of Ni and Ni compounds and particularly to elucidate if Ni in NP-form 
(Ni and NiO) act via different mechanisms compared to soluble Ni (NiCl2), figure 5. The 
specific aims of the included studies were: 
o To investigate genotoxicity and mutagenicity of Ni and NiO NPs compared to Ni 
ions/complexes from NiCl2 using different methods and in vitro models (study I). 
 
o To investigate the ability of Ni and NiO NPs to alter genome stability in human 
bronchial epithelial BEAS-2B cells and to discern possible mechanisms (study II) 
 
o To investigate inflammation and genotoxicity caused by Ni and NiO NPs as well as to 
explore the possibility to test secondary (inflammation-driven) genotoxicity in vitro 
(study III) 
 
o To investigate Ni-induced cellular changes of relevance for cancer with a focus on 
epithelial to mesenchymal transition and a stem cell like phenotype (study IV) 
 
 
 
Ni NPs, NiO NPs 
 & NiCl2 
Cancer mechanisms? 
Genotoxicity 
Mutagenicity 
EMT 
Inflammation 
Figure 5. Overview of the aims of the studies. 
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3 METHODS 
In this chapter the principals of the methods used in this thesis will be described. Detailed 
technical information can be found in the materials and methods section for each associated 
study.  
3.1 NANOMATERIALS 
 
Table 3. Nanoparticles used in this thesis. 
NP BET-areaa (m2/g) Primary sizeb (nm) 
Ni 6.41 <100 
NiO 102 <50 
a Data reported in Latvala et al. (2016). 
b TEM images shown in Di Bucchianico et al. (2018), Kain et al. (2012) and Latvala et al. (2016). 
 
3.2 CELL MODELS 
The cell line HBEC3-KT, used in study I and III, are normal human bronchial epithelial cells, 
immortalized by transfection with a retroviral construct containing cyclin-dependent kinase 4 
and human telomerase reverse transcriptase. They do not form tumours in mice or colonies in 
soft agar (Ramirez et al. 2004). Furthermore, full malignant phenotype could not be 
confirmed after inducing multiple oncogenic changes (K-RASV12, p53 knockdown, mutant 
EGFRs) (Sato et al. 2006). Hence HBEC3-KT are suitable to use as an in vitro model to 
mimic “normal lung cells” as they are considered to display a non-cancerous phenotype. 
The cell line BEAS-2B, used in study II and IV, are human bronchial epithelial cells obtained 
from non-cancerous individuals and immortalized with 12-SV40 virus (Reddel 1989). They 
do not form tumours in mice but they can undergo squamous differentiation in the presence 
of serum (Lechner et al. 1984; Reddel 1989). BEAS-2B has been suggested to be an 
appropriate in vitro model to study heavy metal induced carcinogenesis (Park et al. 2015) and 
it has been used to study malignant transformation after exposure to chromium and arsenite 
(He et al. 2013; Zhang et al. 2012).  
The cancerous cell line THP-1, used in study III, are human monocyte cells originally 
obtained from a 1 year old infant with acute monocytic leukemia (Tsuchiya et al. 1980). 
THP-1 monocytes can be differentiated into macrophages with the ester phorbol 12-myristate 
13-acetate (PMA) and acquire phenotypic as well as functional characteristics reassembling 
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primary macrophages. After differentiation the cells stop proliferating, change morphology 
and become adherent to the cell culture plastic (Auwerx 1991).  
3.3 CHARACTERIZATION OF NANOMATERIALS 
3.3.1 X-ray Photoelectron Spectroscopy  
X-ray photoelectron spectroscopy (XPS), used in study II, is a spectroscopic technique that 
can be used to analyze the surface chemistry of a material. Elemental composition, chemical 
state, empirical formula and electronic state of the elements within a material can be 
measured using XPS. A surface is irradiated by a beam of X-rays while the kinetic energy is 
measured simultaneously and emitted electrons from the 1-10 nm top of the material are 
analyzed which results in a XPS spectra. Electrons over a range of electron kinetic energies 
are counted and a photoelectron spectrum is then recorded. Atoms which emits electrons of a 
particular characteristic energy generates peaks in a spectrum. Identification and 
quantification of surface elements can be interpreted from energies and intensities of the 
photoelectron peaks.  
3.3.2 Photon Cross-correlation Spectroscopy  
Photon cross-correlation spectroscopy (PCCS), used in study I and II is used to measure 
particle size distribution. In PCCS the sample is illuminated by two beams, at different 
azimuthal angles, which were split from the initial light source. Two detectors are used to 
collect the scattered light, collected at two scattering planes, with exactly the same scattering 
vector and the light intensities are cross-correlated. Multiple scattered lights, has no cross-
correlation hence it is filtered out and remaining is the single scattering. The two lights have 
to match precisely otherwise they will not be correlated (Xu 2008).  
3.3.3 Transmission Electron Microscopy 
Transmission electron microscopy (TEM), used in study II, is often used to visualize 
intracellular location of nanomaterials as well as information about their size, shape or 
aggregation state. A beam of electrons is transmitted through the sample and then forms an 
image on a screen. The resolution in TEM is significantly higher than in a regular light 
microscope which enables detection of even single column atoms (Asadabad and Eskandari 
2015).  
3.3.4 Inductively Coupled Plasma Mass Spectrometry 
Inductively coupled plasma mass spectrometry (ICP-MS), used in study I, II and III, can 
detect metals at low concentrations. The sample is ionized by inductively coupled plasma and 
then the mass spectrometer is used to separate and quantify the ions. It can be used to study 
release of metal from for instance NPs in cell media and hence give information on the 
stability of the particles or release of ions (Laborda et al. 2016). 
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3.4 CELL VIABILITY – ALAMAR BLUE ASSAY 
Alamar blue assay, used in study I, III and IV, is one of the most referenced assays used for 
cell viability and cytotoxicity and has been used for 50 years in biological as well as 
environmental studies. The assay monitors the reducing environment of living cells where the 
active ingredient is resazurin which is a blue non-fluorescent dye that is reduced to the highly 
fluorescent pink resorufin by metabolically active cells. The dye accepts electrons in the 
electron transport chain and then changes color, without interfering with the normal transfer 
of electrons. Fluorescent signals can then be measured at excitation wavelength 530-560 nm 
and emission wavelength 590 nm. The advantages with the assay are; high sensitivity and 
linearity, provides accurate time-course measurements, ideal for the use with post-
measurement functional assays, involves no cell lysis, scalable and can be used with 
absorbance- and/or fluorescence-based instrumentation platforms, flexible because it can be 
used with different cell models and finally, non-toxic as well as non-radioactive and safe for 
the user, as well as the environment (Rampersad 2012). 
3.5 EVALUATION OF ROS GENERATION 
The H2DCF-DA (dihydrodichlorofluorescein diacetate) assay, used in study I, II and III, is 
commonly used to detect intracellular ROS. H2DCF-DA is distributed to the cells and 
oxidation of the compound to DCF is measured over time. H2DCF-DA is non-fluorescent in 
its form but since it is a lipophilic ester it can easily cross the plasma membrane and enter the 
cytosol where it is cleaved to DCF by unspecific esterases. DCF is a fluorochrome that after 
excitation with blue light, at around 488 nm, emits green light, around 525 nm, which can be 
measured using a plate reader. The measured brightness of the fluorescence is supposed to 
reflect the presence of ROS but cannot tell which type of ROS (Halliwell and Whiteman 
2004). 
3.6 FLOW CYTOMETRY 
Flow cytometry, used in study I, II and IV, can be used to measure physical and chemical 
characteristics of a cell or particle population. The technique offers quick analysis of 
thousands of cells/particles per second as well as multi-parameter analysis of single cells. 
Four main components are found inside the instrument; fluidics (generating a sheath fluid 
consisting of single cells), excitation optics (consisting of multiple lasers), collection optics 
(transmitting the emitted wavelengths to the photomultiplier tube/detector arrays in multiple 
angles) and analyzer (transforming electrical signals to digital signals and displaying 
quantitative and qualitative data). The cells/particles in suspension are directed to go through 
a laser beam, one cell at the time hydrodynamically focused in a stream, and the light is 
scattered and absorbed by detectors and signals are processed and digitized for analysis by a 
computer. The cells are usually stained with fluorescent markers such as antibodies 
conjugated with a flourochrome which can be excited by the laser beam. The excited energy 
is released as a light photon with specific spectral properties that are different for different 
fluorochromes. Several detectors are aimed at the point where light beam and stream meet to 
detect forward scatter (FSC), side scatter (SSC) as well as fluorescence. FSC can be used to 
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determine size and SSC for granularity/complexity of the cell/particle. Flow cytometry are 
used in research, clinical trials and clinical practice and can be used for detection of; 
cytoplasmic complexity/granularity, nucleic acid content, various intracellular/membrane 
proteins, cell counting, cell size and volume, expression of cell surface and intracellular 
molecules, purity of isolated subpopulations as well as diagnosis of health disorders and 
sorting of cells (Woo et al. 2014). 
3.7 TOXTRACKER 
The Toxtracker genotoxicity assay, used in study I, is based on six mouse embryonic reporter 
cell lines (mES cells). mES cells in comparison to cancer cell lines are genetically stable and 
proficient in all cellular pathways required for accurate detection of potentially carcinogenic 
properties of compounds. Each cell line is transfected with the reporter gene GFP (green 
fluorescent protein) which have been inserted in the promoter region of the gene of interest. 
This assay contains a panel of six reporters marking genes of interest for different endpoints 
considered important in carcinogenesis; Bscl2 and Rtkn: DNA damage, Srxn1 and Blvrb: 
oxitative stress, Ddit3: protein damage and Btg2: cellular stress. When these transfected cells 
are exposed to a chemical/xenobiotic that will activate transcription of the gene of interest 
they will exhibit fluorescence. The fluorescence is detected using flow cytometry and the 
cells are usually seeded in a 96 well plate which allows for higher throughput. This panel of 
genes was selected by exposure to over 40 different carcinogenic chemicals following whole-
genome transcription profiling (Hendriks et al. 2016). 
3.8 HPRT-MUTATION ASSAY 
The hypoxanthine phosphorybosyl transferase (HPRT) gene, situated on the X-chromosome, 
is used as a model to detect mutations in mammalian cell lines after exposure to chemicals. 
The assay, used in study I, is included in guidelines for mammalian gene mutation tests 
OECD (1997), Organisation for Economic Co-operation and Development. After exposure 
and fixation of the mutation in the cells the compound 6-thioguanine is added. 6-thioguanine, 
an analogue to the purine base guanine, will incorporate itself in the DNA and terminate the 
cells which did not gain mutation in the HPRT-gene. The cells which acquired mutation in 
the HPRT-gene will survive and present as colonies. Colony forming efficiency (CFE) are 
used to measure cell viability after initial exposure and before exposure to 6-tioguanine. The 
assay responds to a broad spectrum of mutagens unlike other bacterial assays (Johnson 2012). 
figure 6 shows a schematic presentation of the steps included in the assay. 
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Figure 6. Schematic overview of the HPRT-mutation assay. 
 
3.9 COMET ASSAY 
The comet assay, used in study I, II and III, also referred to as “single-cell gel 
electrophoresis”, is most widely used in the alkaline version, where using a pH over 13 
enables the detection of single-strand breaks in the DNA. The single-strand breaks can be 
associated with alkali-labile sites and incomplete excision repair. In short, cells are (after 
exposure) harvested, embedded in agarose-gel on a microscope slide and lysed. The lysis 
solution contains Triton X-100, which breaks down the membranes, and also NaCl in a high 
concentration that removes histones and other soluble proteins. The supercoiled DNA 
attaches to a nuclear matrix and a structure named ”nucleoid” is created. The DNA is then 
unwound by incubation in alkaline electrophoresis buffer and the electrophoresis is further 
executed under the same conditions. The damaged DNA is negatively charged and migrates 
towards the anode during the electrophoresis which results in an appearance of comet-like 
structure with a head and a tail. The next steps are neutralization and fixation following 
staining of the DNA. The comets can then be visually analyzed using a fluorescent 
microscope with the help of a software specific for the assay. Different parameters for each 
comet are calculated and the most commonly used ones are; tail length, percentage DNA in 
the tail and tail moment (tail length × the total tail intensity). Percentage tail DNA is 
generally regarded as more useful and easier to interpret, and therefore recommended to use. 
Oxidatively damaged DNA can also be detected by a modification of the assay. A lesion 
specific endonuclease is added following the lysis. This will remove the damaged base and 
create an abasic site that becomes transformed into a strand break by the lyase activity of the 
enzyme, or by the alkaline treatment step. One of the common enzymes used are 
formamidopyrimidine DNA glycosylase (FPG) that recognize oxidatively damaged purines 
mainly formamidopyrimidines and 8-oxoguanine (Karlsson et al. 2015).  
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3.10 MICRONUCLEUS ASSAY 
The micronucleus assay, used in study II, can be used for evaluation of cytogenetic damage 
after exposure to chemicals. When inclusion of acentric or whole chromosomes in the 
daughter nuclei fails, micronuclei are formed. This occurs because they cannot attach to the 
mitotic spindle and migrate to the poles in the anaphase in the cell division. Reasons behind 
formation of micronuclei can be; defects in the kinetochore assembly, unresolved replication 
stress, dysfunctional spindle or unrepaired double strand breaks. Cytochalasin B, added to 
cells after exposure, inhibits cytokinesis and enables distinction of cells that underwent cell 
division, which will appear binucleated. This enables for scoring of only binucleated cells and 
the confounding effects of impaired kinetics of cell division are reduced. In this way, only 
cells that were damaged during exposure are scored. Cells are allowed to grow for a period of 
time sufficient for chromosomal damage to occur leading to the formation of micronuclei in 
bi-or multinucleated cells in interphase. The cells are then harvested and stained and analyzed 
by microscope for the presence of micronuclei (Fenech 2007; Fenech et al. 2011) 
3.11 PROTEOME PROFILER ANTIBODY ARRAY 
Proteome ProfilerTM Antibody Arrays, used in study IV, are commercially available kits from 
R&D Systems that allows for parallel detection of the relative levels of a selection of 
proteins. The technique is a membrane-based sandwich immunoassay. Proteins in the sample 
bind to capture antibodies on a membrane and biotinylated detection antibodies in turn bind 
to the proteins. The results are visualized with chemiluminescent detection reagents and the 
signal is proportional to the bound analyte (figure 7). The Proteome Profiler Human XL 
Cytokine Array Kit can detect 105 different cytokines. The Proteome Profiler Human 
Chemokine Array Kit can detect 31 different chemokines.  
 
Figure 7. Principal of the Proteome ProfilerTM Antibody Arrays. 
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3.12 MULITPLEX ASSAY 
The purpose of multiplex arrays, used in study III, is to measure multiple cytokines at the 
same time from the same sample. The most common detection method is by flow cytometry, 
which is based on beads. The beads are coated with specific capture antibodies which the 
proteins in the sample bind to. Detection antibodies conjugated with a flourochrome binds to 
the protein and creates a cytokine-capture antibody complex on the bead set, similar to figure 
7. Multiple cytokines in a liquid sample can thus be recognized using a setup of different 
bead sets (Leng et al. 2008).  
3.13 IMMUNOFLUORESCENCE 
Immunofluorescence, used in study IV, is a method that gives information about the structure 
of the cell and the locations of specific molecules. The cell or tissue of investigation is 
incubated with an antibody specific to the target of interest. A secondary antibody is then 
added conjugated to a fluorophore which makes it possible to detect the signal by a 
fluorescent microscope (Donaldson 2015). 
3.14 IN-CELL WESTERN 
In-cell western, used in study IV, is a quantitative immunofluorescence assay used to measure 
specific proteins inside or on cells. It can be described as a combination of western blot and 
ELISA. Cells are cultured in a 96- or 384-well plate, fixed, permeabilized, blocked for 
unspecific binding and incubated with a primary antibody. The next steps are washing and 
incubation with a secondary antibody which is conjugated to an infrared dye. The infrared 
dye is excited with a laser and emits fluorescence which is detected by a scanner, which reads 
the culture plate. The scanner can detect two targets in the same sample as it has two 
detection channels. This allows for normalization to the cell number as the cells can be 
stained with a cell-tag infrared dye. Detection of proteins in their cellular context increases 
the precision of quantification. 
3.15 REAL-TIME PCR 
Real-time polymerase chain reaction (PCR), used in study IV, is based on the conventional 
PCR but the difference is that the reaction is monitored in real-time. The products generated 
during each cycle of the PCR process are detected and measured and are directly proportional 
to the starting amount of template. The readout is a fluorescent signal and measurement is 
registered after each round of amplification and the results are presented in an amplification 
plot that takes the shape of a linear sigmoid curve. If the amplification is 100% efficient it 
results in doubling of the PCR product in each cycle and this occurs in the exponential phase. 
The fractional PCR cycle number where the reporter fluorescence is greater than the minimal 
detection level is called the threshold cycle (CT) and it represents the parameter used for 
quantification and it is used to compare samples (Arya et al. 2005).  
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3.16 THE SCRATCH WOUND HEALING ASSAY 
The purpose of the scratch wound healing assay, used in study IV, is to study cell migration 
in vitro. The method is fairly simple and the principal is based on a creation of an artificial 
scratch in the confluent cell monolayer. The cells in the edge on the scratch will then move 
and try to close the scratch. This process is monitored by taking pictures just after the scratch 
is created, and with regular time intervals and then comparison of the pictures will be 
performed to determine the cell migration rate (Liang et al. 2007).  
3.17 INVASION/MIGRATION ASSAY 
The transwell invasion/migration assay, used in study IV, is commonly used in cancer 
research and can be used to study if cells can migrate spontaneously or migrate toward a 
chemoattractant. The cells are plated in the top well of one setup of transwells containing 
appropriately sized pores for studying migration and another setup of transwells containing 
matrigel for invasion. The chemoattractant are placed in the bottom well. The cells are then 
allowed to migrate or invade through the top well and these cells are then stained and counted 
in a microscope. The results can be presented as either the number of migrating and invading 
cells separately or by calculating the invasion index by the ratio of invading/migrating cells 
(Justus et al. 2014). 
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4 RESULTS 
4.1 STUDY I: GENOTOXIC AND MUTAGENIC PROPERTIES OF NI AND NIO 
NANOPARTICLES INVESTIGATED BY COMET ASSAY, Γ-H2AX 
STAINING, HPRT MUTATION ASSAY AND TOXTRACKER REPORTER 
CELL LINES 
The aim of this study was to study genotoxicity of Ni and NiO NPs in comparison to Ni 
ions/complexes from soluble NiCl2 using different model systems. 
Cytotoxicity was measured and Ni and NiO NPs were found to be non-cytotoxic at the doses 
tested while NiCl2 caused a slight decrease in viability at the highest dose. Next, the comet 
assay was performed and Ni and NiO NPs induced DNA strand breaks at the doses tested (5-
25 µg/mL) while NiCl2 did not. Thereafter, γ-H2AX staining using flow cytometry was 
conducted to investigate the formation of double strand breaks. The results showed no 
significant induction of γ-H2AX foci in neither of the doses tested (5-25 µg/mL). The 
exposure time was 24 h for all the experiments.  
The DCFH-DA assay was employed to investigate intracellular ROS generation. A 
statistically significant increase was observed for Ni and NiO NPs at the higher doses (25 and 
50 µg/mL), while no significant changes could be observed for NiCl2. 
Six different reporter cell lines (ToxTracker) were used to investigate the underlying 
mechanisms of the genotoxicity of Ni and NiO NPs. Cell viability was initially measured 
with the aim to determine test concentrations reaching up to approx. 50% cytotoxicity and 
large differences between Ni NPs, NiO NPs and NiCl2 was observed. Ni NPs could further 
only be tested at doses up to 5 µg/mL because they were found considerably more cytotoxic 
than NiO NPs and NiCl2. The NiO NPs and Ni ions were tested at doses up to 100 µg/mL. 
The oxidative stress reporter Srxn1 was triggered by all compounds tested, where an increase 
was found at low doses (below 1 µg/mL) for Ni NPs, at higher doses (5-10 µg/mL) for NiO 
NPs and even higher doses (30-50 µg/mL) for NiCl2. The Bscl2 reporter for stalled 
replication forks was not induced by any of the exposures. Rtkn, the reporter for NFκB 
signaling, showed a small increase for all the three compounds. The reporter for protein 
stress, Ddit3, was induced at the highest doses for all the three compounds. 
The Hprt gene mutation assay in mES cells and V79-4 cells was employed to test 
mutagenicity of Ni NPs, NiO NPs and NiCl2. There was a slight increase in the mutant 
frequency in the mES cells for some of the Ni, NiO and NiCl2-exposures but statistical 
significance was only found for one dose (0.5 µg/mL) of NiO. Due to large variation between 
the experiments no statistically significant increase in mutation frequency could be observed 
for the V79-4 cells. The results from this study are concluded in table 5. 
 
 
 32 
 
Table 5. Concluding table of the results presented in study I. 
 Ni  NiO  NiCl2 
Cytotoxicity HBEC  ≤50 µg/mL No No Minor at 50 
µg/mL 
DNA strand breaks HBEC  ≤25 µg/mL Yes from  
10 µg/mL 
Yes from  
5 µg/mL 
No 
DNA double strand breaks HBEC ≤25 µg/mL No No No 
Cell-free ROS Minor Yes Minor 
Intracellular ROS HBEC ≤50 µg/mL Minor Yes No 
Cytotoxicity reporter cells Yes Yes Yes 
Oxidative stress reporter induction Yes Yes Yes 
DNA damage reporter induction No1 No1 No1 
Protein stress reporter induction Yes, at high 
cytotoxicity 
Yes, at high 
cytotoxicity 
Yes at high 
cytotoxicity 
Hprt mutations mES cells ≤5 µg/mL No At one dose No 
1A modest increase in Rtkn reporter but not reaching the ×2 threshold 
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4.2 STUDY II: CALCIUM-DEPENDENT CYTO- AND GENOTOXICITY OF 
NICKEL METAL AND NICKEL OXIDE NANOPARTICLES IN HUMAN LUNG 
CELLS 
The aim of the study was to in depth study the ability of well characterized Ni and NiO NPs 
to alter genome stability in comparison to Ni ions/complexes from soluble NiCl2 and to 
investigate underlying mechanisms in BEAS-2B cells.  
Characterization of the NPs was initially performed. TEM analysis showed a variation in size 
but in general Ni NPs were less than 100 nm and NiO NPs less than 50 nm. The intrinsic 
ROS generating ability was analyzed by the DCFH assay. NiO NPs was highly reactive in the 
absence of HRP whereas Ni and NiO showed similar but smaller effects in the presence of 
HRP. No effects were observed for NiCl2. 
The hydrodynamic size and light scattering using PCCS as well as the dissolution/Ni release 
by means of ICP-MS was performed to characterize the behavior of the NPs in cell medium. 
Directly after dispersion (0 h), agglomeration of Ni and NiO NPs in cell medium occurred 
with an average size around 500 nm for the Ni NPs and 750 nm for NiO NPs. Measurements 
after 2 and 24 h showed similar characteristic as the cell medium, which indicates that the 
particles was removed from the solution by sedimentation. Release of Ni in solution was 
increased with time and around 5% and 9 % Ni release was observed after 48 h for Ni and 
NiO NPs, respectively, at the highest concentration. No significant differences could be found 
between Ni and NiO NPs at the lower concentrations (1 and 5 μg Ni/mL) after 48 h. In 
regards to uptake, TEM was applied and the results showed that both Ni and NiO NPs were 
taken up by BEAS-2B cells. The cellular content of Ni after 48 h exposure was also measured 
with ICP-MS, where uptake was observed for Ni (40 μg) and NiO (60 μg) measured per 
million cells, whereas there was no significant uptake of NiCl2. 
Annexin V/PI staining was performed to measure apoptosis and necrosis after NiCl2, Ni and 
NiO NP exposures at concentrations of 1, 5 and 10 μg Ni/ml. There was a dose dependent 
increase in apoptosis for Ni and NiO NPs whereas NiO was the most potent. Regarding 
necrosis, an increase by concentration was also observed where the effect was apparent 
particularly at the highest concentrations (10 μg Ni/mL) of NiO NPs and NiCl2. The same 
trend was also observed in the CBMN Cyt assay. The replication index was increased by the 
lowest concentration of Ni NPs tested while the highest concentration of NiO NPs and NiCl2 
showed a significant cytostatic effect and a reduction of the mitotic index.  
The comet assay was employed for investigation of DNA strand breaks and the results 
showed a significant increase in all concentrations tested (1, 5 and 10 μg/mL) for all three 
compounds, however NiO NPs was found to be most potent causing a threefold increase. 
Intracellular ROS was also measured with the DCFH-DA assay and a significant increase 
was observed in response to NiO NPs (1, 5 and 10 μg/mL) as well as NiCl2 (5 and 10 
μg/mL). Intracellular calcium levels were measured using the fluorescent probe Fluo-4, with 
an exposure of 5 μg/mL. A significant increase was observed for NiO NPs and NiCl2, while 
higher variation among experiments led to a non-statistically significant increase for Ni NPs.  
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The frequency of micronuclei (MN), nucleoplasmic bridges (NPB) and nuclear buds (NBUD) 
were analyzed. A significant increase in MN binucleated cells could be observed for all the 
exposures at the two highest concentrations, where NiO NPs were found to be most potent. 
Ni NPs and NiCl2 were more potent than NiO NPs in inducing MN in mononucleated cells, 
NBPs as well as NBUDs. The effects on calcium and iron were evaluated using the same 
assay in combination with various chelators and inhibitors. Cells were co-exposed to calcium 
modulators or one iron modulator and the different Ni exposures (NiCl2, Ni and NiO NPs) in 
concentration of 5 μg Ni/mL. A significant reduction in MN induced by NiO NPs and NiCl2 
was observed after co-exposure with the iron chelator deferoxamine while Ni NPs showed a 
smaller difference. Similar results were seen for NPB and NBUD. After co-exposure to the 
calcium modulators BAPTA-AM (Ca2+ chelator) and verapamil (inhibits calcium uptake 
through the plasma membrane) the genotoxicity was reverted to control values for all the Ni 
exposures. Co-exposure with dantrolene (prevention of Ca2+ release from the endoplasmic 
reticulum) was protective against genotoxicity induced by Ni and NiO NPs but not by NiCl2. 
Similarly, protective effects were also shown for apoptosis and necrosis induced by NiO NPs. 
A summary of the results are presented in figure 8. 
 
 
Figure 8. Summary of the results presented in study II. 
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4.3 STUDY III: INFLAMMATION AND (SECONDARY) GENOTOXICITY OF NI 
AND NIO NANOPARTICLES 
To this date, few studies have been performed on the secondary genotoxicity of NPs in vitro. 
The aim of this study was to test the hypothesis that Ni and NiO NPs can cause both primary 
and secondary genotoxicity in vitro. 
The cytotoxicity was measured after exposure to Ni and NiO NPs at concentrations of 5, 10, 
25 and 50 µg/ml for 3 and 24 h in THP-1 derived macrophages (THP-1*) and HBEC cells. 
No cytotoxic effect was observed in response to Ni and NiO NPs in HBEC cells while in 
THP-1* a decrease in cell viability could be observed in the highest concentrations after 24 h.  
The proteome profiler antibody array was used to investigate release of cytokines from THP-
1* cells exposed to 50 µg/ml Ni and NiO NPs, after 3 and 18 h exposure. 105 different 
cytokines and 31 chemokines (only used after 3 h exposure) were analyzed. Quartz (SiO2) 
was included as a benchmark particle for comparison. The release of the following cytokines 
was increased after 3 h exposure; MIF, IFN-γ, IGFBP-3, IL-17A and IL-12p70 (based on two 
times cut-off). No increased release was observed for the chemokines except from ENA-78 
(NiO NPs exposure). The release of the following cytokines was increased after 18 h 
exposure; CD40 Ligand, C-Reactive Protein, Fas Ligand, FGF basic, Flt-3 Ligand, IL-1α, IL-
1β, VEGF and G-CSF. In general, the trend was similar for Ni and NiO as well as the SiO2 
benchmark particle. VEGF was an exception where an increase was seen for Ni and NiO but 
not for SiO2. Furthermore, some cytokines were specific for SiO2 including IL-17A, IP10 and 
MCP1. VEGF and IL1β were also measured by Luminex. Ni and NiO, but not SiO2, caused 
an increase of VEGF after 18 h exposure. A small, non-statistically significant increase for 
IL-1β was observed after 18 h. 
Thereafter we wanted to investigate if secreted factors from the exposed macrophages (50 
µg/ml of Ni, NiO NPs and SiO2) could induce DNA damage in HBEC cells. HBEC cells 
were exposed to conditioned media (CM), figure 9A, generated from the 3 and 18 h exposed 
macrophages, and further investigated by the comet assay. The genotoxic effect directly 
caused by Ni, NiO NPs and SiO2 was also tested (10 µg/ml, 3 h) as well as the combined 
exposure NPs+CM. The CM, NPs as well as the combination of CM and NPs induced 
statistically significant DNA damage compared to control (2.4% DNA in tail). CM from Ni 
and NiO NPs caused 7.3% and 8.7% DNA in tail, respectively, which is comparable to the 
damage induced directly by the NPs (10 µg/ml), being 9.2% and 11.6% DNA in tail for Ni 
and NiO NPs, respectively. The damage was also comparable to the combined exposure from 
NPs+CM, hence no additive effect was observed. 
The cells were also cultured in a transwell co-culture system, figure 9B, with THP-1* in the 
top well and HBEC cells in the bottom well. The THP-1* cells were exposed to 50 μg/ml of 
Ni, NiO and SiO2 NPs for 3 and 18 h. The HBEC cells were then further analyzed by comet 
assay. Exposure to Ni and NiO NPs resulted in a significant increase in DNA strand breaks 
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compared to control while SiO2 only showed a small non-significant increase, for both 3 and 
18 h. 
 
Figure 9. Descriptive figure of conditioned media (A) and co-culture system (B). 
We investigated the amount of released Ni present in CM generated from Ni and NiO NP 
exposed THP-1* for 3 h and 18 h, and compared it to the total amount of added Ni and NiO 
NPs (50 µg/ml). The percentage of Ni released from Ni and NiO NPs were 1.4% and 2.3% 
after 3 h, respectively as well as 2.3% and 5.5%, respectively, after 18 h. We also used the 
DCFH-DA assay to measure ROS, however we were not able to measure any increased ROS 
in the CM but an increase in intracellular ROS was observed in HBEC cells after exposure to 
CM from NiO NP exposed THP-1*. 
In conclusion Ni and NiO NPs induce a release of inflammatory cytokines from exposed 
macrophages. Furthermore, the detection of secondary genotoxicity in epithelial lung cells by 
using in vitro methods based on conditioned medium or co-cultures was found possible. In 
order to find out what factors are causing this secondary genotoxicity further investigation is 
needed.   
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4.4 STUDY IV: NI AND NIO NANOPARTICLES CAUSE CHANGES LINKED TO 
EPITHELIAL-MESENCHYMAL TRANSITION (EMT) AND A STEM CELL 
LIKE PHENOTYPE IN EPITHELIAL LUNG CELLS 
BEAS-2B cells were exposed to Ni NPs, NiO NPs and NiCl2 in concentrations of 0.5, 1, 5 
and 10 μg Ni/ml for cytotoxicity measurement after 48 h exposure. Significant cytotoxicity 
was observed in response to Ni at 10 μg Ni/ml as well as for NiO at 5 and 10 μg Ni/ml. 
We investigated mRNA expression of eight different genes associated to cancer and EMT 
after exposure to 1, 5 and 10 μg Ni/ml. Two tumor suppressor genes, APC and CDKN2A 
were downregulated by all of the Ni compounds (except no significance for Ni and APC). We 
also found that E-cadherin was downregulated by all of the Ni compounds in the higher doses 
(5 and 10 μg Ni/ml). No increase of mRNA expression of mesenchymal markers fibronectin, 
vimentin and N-cadherin could however be observed.  
Protein expression of epithelial markers E-cadherin and EpCAM was measured with flow 
cytometry and a dose dependent down regulation in E-cadherin was observed (significant at 
the highest doses). A decrease in E-cadherin and an increase in Fibronectin and Vimentin was 
also confirmed by In-cell western and immunofluorescence (5 μg Ni/ml).  
We wanted to investigate if the previous results had implications on a functional level and  
the scratch wound healing assay was further used (doses 1 and 5 μg Ni/ml) as well as the 
invasion/migration assay (5 μg Ni/ml). A significant increase in wound healing was observed 
for Ni 1 μg Ni/ml and NiCl2 5 μg Ni/ml. The results from the invasion migration showed a 
significant increase for Ni and NiO NPs.  
Further we wanted to investigate if the Ni-exposures could induce a stem cell like phenotype 
and we investigated expression of three stem cell markers CD24, CD44 and c-KIT. CD24 
expression was found to be significantly downregulated both on mRNA and protein level by 
the higher concentrations in Ni and NiO NPs and NiCl2. c-KIT protein expression was 
significantly upregulated by the higher concentrations in the exposures as well as mRNA 
expression (Ni 5 and NiO 10 μg Ni/ml). No upregulation could however be observed in 
CD44 expression.  
In conclusion, both Ni and NiO NPs were found to induce changes linked to EMT and a stem 
cell line phenotype and the observed effects were comparable for ionic Ni and NPs.  
  
 38 
5 DISCUSSION 
5.1 PRIMARY GENTOTOXICITY 
An important question in the geno-toxicological field is if genotoxicity is caused by direct 
DNA-interactions or non DNA-reactive mechanisms. In study I we showed that the main 
mechanism of toxicity was ROS for Ni and NiO NPs. Importantly, none of the Ni-materials 
induced the ToxTracker reporter related to direct DNA damage and stalled replication forks; 
a reporter that is activated by many genotoxic carcinogens. In line with these results 
intracellular ROS was also induced in study II. Other studies have previously demonstrated 
genotoxicity in the form of DNA-strand breaks in cell models using the same NiO NPs as in 
this thesis (Kain et al. 2012; Latvala et al. 2016) and others (Ahamed and Alhadlaq 2014; 
Alarifi et al. 2014; Magaye et al. 2016). An interesting difference between study I and II is 
that no DNA strand formation and intracellular ROS was formed after exposure to NiCl2 in 
study I (HBEC, 24 h) whereas this was observed in study II (BEAS-2B, 48 h). There is no 
clear explanation for these observations other than that the exposure time and cell type 
differed between the studies. Both cell types are cultured under serum-free conditions, 
although using different cell media and additives. Furthermore, we showed in study II that Ni 
and NiO NPs as well as NiCl2 induced chromosomal damage and rearrangements. In this 
study we also measured the cell uptake (by ICP-MS) and could, importantly, show that Ni 
and NiO NPs are taken up by BEAS-2B cells while this was not the case for NiCl2. This led 
to the search for membrane/receptor based mechanisms. Since calcium levels were found to 
be elevated after exposure to the three Ni-exposures, in line with another study where high 
doses of soluble green Ni carbonate hydroxide were used (M'Bemba-Meka et al. 2006), we 
tested the hypothesis that calcium was involved. We found that three different calcium 
modulators prevented chromosomal damage for Ni and NiO NP exposure and that two of 
them acted preventive for NiCl2 exposure. In addition the iron chelator deferoxamine was 
shown to reduce the NiO- and NiCl2-induced increase in MN to levels near the control value. 
Our results are in line with previous studies which showed a protective effect of both calcium 
modulators and deferoxamine for the formation of DNA strand breaks and sister-chromatid 
exchange using soluble green Ni carbonate hydroxide exposed lymphocytes (M'Bemba-Meka 
et al. 2005; M'Bemba-Meka et al. 2007). Oxidative stress and modulation of intracellular 
calcium as primary mechanism of genotoxicity may suggest a threshold dose-response 
compared to agents that interact directly with DNA. This is also supported by the low 
mutagenic potential observed in study I.  
5.2 SECONDARY GENOTOXICITY 
In study III we tested the hypothesis that secondary genotoxicity could be induced by Ni and 
NiO NPs. Using a conditioned media approach as well as a co-culture transwell model we 
interestingly saw an increase in DNA-strand breaks induced in HBEC cells in both assays. 
Unfortunately we have not yet found what is causing this effect. In study I we showed lack of 
DNA strand break induction by NiCl2 in HBEC cells and because of this it is unlikely that the 
observed secondary genotoxicity would be due to dissolved Ni. One hypothesis is that the 
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effects are due to ROS produced by macrophages which undergoes oxidative burst. We made 
various attempts to test increased ROS in the conditioned media using DCFH-DA and 
another probe HPF but without success so far. Further experiments are needed to find 
possible factors causing the observed secondary genotoxicity.  An assay called Amplex red 
has previously been used to measure H2O2 which could be of interest to us (Wiemann et al. 
2016). It could also be of interest to investigate the relationship between cytokines such as IL-
β and TNFα and the production of intracellular nitric oxide, as shown before (Green et al. 
1994). 
To the best of our knowledge, no other studies including NPs and co-culture models 
investigating secondary genotoxicity using genotoxicity assays as the endpoint have yet been 
published, hence comparison is difficult. Secondary genotoxicity is noted as the main 
mechanism of genotoxicity in vivo. An issue is that most of the standard in vitro models 
assess primary genotoxicity based on single cell systems which are not always representable 
for what occurs in vivo (Catalan et al. 2017; Evans et al. 2017). Hence, more studies on in 
vitro systems which represent secondary genotoxicity are needed. It is also of importance to 
develop such systems to attend to the three Rs i.e. replacement, reduction and refinement of 
animal experiments. The use of a conditioned media approach and a co-culture model was an 
attempt to better mimic an in vivo situation, but in its most simplistic form to study secondary 
genotoxicity. However, more expensive advanced systems such as 3D cultures and micro 
tissues could also be used to study the same endpoint.  
5.3 NON GENOTOXIC MECHANISMS 
In study IV we wanted to study cancer mechanisms not related to genotoxicity. EMT is a 
mechanism which has been related to metastasis, and  loss of E-cadherin is considered to be a 
hallmark of EMT (Thiery et al. 2009).  Interestingly, we observed a clear and dose dependent 
decrease in E-cadherin at both mRNA and protein level (study IV). Increased protein 
expression of the mesenchymal markers fibronectin and vimentin was also observed. These 
results are in line with previous studies (Jose et al. 2018; Tang et al. 2013; Wu et al. 2012) 
where soluble Ni (NiCl2 and NiSO4) was used, in BEAS-2B cells as well as A549. In 
addition we found induction of stem cell markers following exposure to NiCl2, Ni and NiO 
NPs. Our results are further strengthened by functional assays showing increased 
invasion/migration which was also shown in Jose et al. (2018). In our study the effects of Ni 
and NiO NPs in addition to NiCl2 was also investigated. To the best of our knowledge there 
are no previous studies investigating effects on EMT after exposure to Ni and NiO NPs. 
However a few previous studies showing effects related to EMT as a consequence of NP-
exposure have been performed (Chang et al. 2017b; Choo et al. 2016; Gliga et al. 2018; Ma et 
al. 2017; Song et al. 2017). E-cadherin is a calcium dependent protein and, interestingly, in 
study II we demonstrate an increase in intracellular calcium after exposure to NiCl2, Ni and 
NiO NPs. Also a decrease in genotoxicity induced by NiCl2, Ni and NiO NPs was observed 
after modulating calcium. A study using breast cancer cells showed a transient increase in 
cytosolic calcium levels after exposure to the stimuli (EGF) used to induce EMT and 
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induction of EMT markers, including vimentin, was almost completely blocked when 
chelating intracellular calcium (Davis et al. 2014). One may speculate that E-cadherin 
decrease could possibly occur because of Ni induced intracellular calcium.  
EMT can be induced by inflammation and loss of E-cadherin mediated cell contact has 
previously been linked to inflammation through induction of NF-κB in cancer cells (Cowell 
et al. 2009). In study III we aimed to explore if inflammatory cytokines could be released 
from macrophages following exposure to Ni and NiO NPs. An increase in several cytokines 
was noted.  Interestingly an increase in MIF (migration inhibitory factor), an inflammatory 
cytokine seen as a pro-tumourigenic factor (Mitchell 2004) was observed. It has been 
suggested that MIF promotes tumour growth and viability by supporting tumour-associated 
angiogenesis and modulating immune responses (Chesney et al. 1999; White et al. 2001). A 
study using cervical cancer cells found that elevation of MIF levels facilitated cell invasion 
and migration as well as resulted in an increase of vimentin and decrease of E-cadherin 
expression (Guo et al. 2018). In addition we found an increase of VEGF (vascular endothelial 
growth factor) which plays a role in pathological angiogenesis associated with tumors 
(Ferrara et al. 2003) and has been shown to activate NF-κB (Kim et al. 2001; Marumo et al. 
1999). Interestingly VEGF mediated angiogenesis was found to link EMT induced cancer 
stemness to tumour initiation in a study using mouse mammary gland epithelial cells 
(Fantozzi et al. 2014). VEGF was also found to enhance angiogenic and tumorigenic capacity 
as well as induce changes leading to gain of EMT characteristics and increased motility of 
prostate cells (Gonzalez-Moreno et al. 2010). Following 18 h exposure, we noted increased 
IL-1α and IL-1β, in line with some previous studies (Cao et al. 2016; Gillespie et al. 2010; 
Morimoto et al. 2010). A study found that IL-1β promotes growth of colon cancer invasion 
through activation of CSC self-renewal and EMT (Li et al. 2012).  
5.4 PARTICLES VS IONS 
The nickel ion bioavailability model states that: “the presence of nickel ions in a substance is 
not sufficient for that substance to be a complete carcinogen” and to act as a carcinogen Ni 
ions that become bioavailable at the nucleus of epithelial lung cells must be released from the 
substance. It is suggested that NiO particles are more potent than metallic Ni particles 
(Goodman et al. 2011). In study II we demonstrated that there were limited to no uptake of 
NiCl2 while Ni and NiO NPs were taken up by the cells. This observation is in line with the 
nickel ion bioavailability model as well as other studies (Hack et al. 2007; Harnett et al. 1982) 
showing that uptake via ion-transport channels of Ni compounds which are soluble in water is 
not as efficient as uptake via endocytosis of Ni-containing particles for delivering Ni ions to 
nuclear sites. The results regarding intracellular ROS, DNA-strand breaks and induction of 
mutations (using the HPRT-mutation assay) using HBEC cells in study I showed that NiO 
NPs were more potent than Ni NPs whereas soluble NiCl2 showed little (mutations, non-
significant) to no potency (ROS and DNA-strand breaks). These results are in line with the 
theory stated in Goodman et al. (2011) in which NiO harbor higher carcinogenic potential 
than metallic Ni. Furthermore it is also of importance to consider the fact that Ni and NiO 
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NPs are expected to induce more severe toxic effects than soluble Ni since their retention in 
the lungs are higher. This was demonstrated in an in vivo study where 40-60% of poorly 
soluble NiO NPs still remained in the lung after 90 days compared to <0.3% for soluble NiO 
nanowires (Shinohara et al. 2017).  
5.5 IMPLICATIONS FOR ASSESSING RISK 
When evaluating risk of a classic toxic compound the limits can be set where no observed 
adverse effect level can be observed as a threshold derived from a sigmoid curve which 
shows a dose-effect relationship. However when it comes to compounds which are shown to 
be genotoxic the principle of setting a threshold is not warranted. The principle that one 
single molecule is sufficient to irreversibly damage DNA and give rise to tumorigenesis is 
applied, hence there is no safe dose for genotoxic compounds. Instead, an increase risk is 
calculated from extrapolating from a dose response seen in animal carcinogenicity 
experiments (Bos et al. 2004).  
We demonstrate genotoxicity of Ni and NiO NPs in study I (comet assay) and study II (comet 
assay, micronucleus assay) which may raise a concern of genotoxic potential. In study III we 
also demonstrate evidence of secondary genotoxicity from Ni and NiO NPs. In vivo studies 
are in general given more importance than in vitro studies when assessing risk. In a recently 
developed approach for weighted assessment of the mutagenic potential of nanomaterials, in 
vitro mammalian assays for DNA-damage were ranked with a high uncertainty and low 
relevance. Furthermore, the comet assay was ranked lower than the micronucleus test and 
assays measuring unrepairable gene mutations (Catalan et al. 2017). Hence, according to this 
approach, study II would be ranked higher than study I and they will be implicated in risk 
assessment with low relevance and high uncertainty.  
Lastly in study IV when investigating non genotoxic mechanisms but other mechanisms 
important in cancer, effects were also observed after exposure to Ni and NiO NPs. 
Specifically we investigated EMT which is a mechanism not related to genotoxicity but to 
metastasis. We demonstrate a dose dependent decrease in E-cadherin induced by Ni and NiO 
NPs, which is a hallmark of EMT. We also demonstrate a decrease of expression in tumor 
suppressor genes and induction of stem cell markers. However, it is unclear how this data 
could be used in risk assessment but the future might hold a place for it.  
5.6 IN VITRO METHODS AND DOSES 
In vitro methods, as used in this thesis, are more cost efficient, simpler and faster compared to 
in vivo methods when investigating endpoints of toxicity. The downside using in vitro models 
are that the metabolic activity has not been fully characterized in cell lines and they are not as 
complex as the human body or animal models. Furthermore there is a problem regarding 
prediction of biodistribution and target organ toxicity in in vitro studies (Kroll et al. 2009). 
Another important aspect of in vitro vs in vivo studies is the dosimetry. How do we choose 
relevant doses for exposure in vitro that are relevant and realistic in vivo? Some studies use 
exaggerated doses that are too high to be of relevance in a realistic exposure scenario in 
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humans. Mathematical models can be used to deal with these concerns (Krug and Wick 
2011). Doses of NPs tested in genotoxicity assays are often required to be comparable to 
possible human exposure scenarios. However human exposure usually occurs at low doses 
over a long period of time and there may be accumulation of NPs which can make it tricky 
(Greim and Norppa 2010). To attempt to compare the doses used in this thesis to an exposure 
scenario the following calculation was used, also used for silver NPs in Wang et al. (2014).  
4-week deposition in the lung of a worker exposed to the Swedish hygenic limit of Ni metal 
total dust: 0.5 mg/m3. The assumption is that the ventilation rate of a healthy human adult in a 
working situation is 20 L/min = 9.6 m3/8 h day). The deposition fraction is 30% and the short 
term clearance is neglible.  
Monthly deposition: 0.5 (mg/m3) x 0.3 (deposition fraction) x 9.6 (m3/day) x 5 (days/week) x 
4 (weeks) = 28.8 mg/person 
Deposition per lung surface area assuming a total surface of 100 m2: 28.8 /100= 0.288 mg/m2 
surface which is 0.0288 μg/cm2. To account for uneven deposition: 10 x 0.0288 =0.288 
μg/cm2 ~ 0.29 μg/cm2. 
To put this in comparison to the concentrations used in study I-IV was ranging between 0.21-
15.63 μg/cm2 which puts the calculated value from the example, 0.29 μg/cm2, in the lower 
end.  
5.7 STRENGTS AND LIMITATIONS OF THE STUDIES 
Strengths of the studies used in this thesis include: 
o The particles used were well characterized.  
o A great number of methods was used to asses mechanisms of carcinogenicity. 
o A number of different types of mechanisms of carcinogenicity were studied. 
o The lung cell lines was non-cancerous which gives a better chance of mimicking the 
real exposure of a healthy lung. 
Limitations of the studies include: 
o Only a single cell line was used in study II, III and IV. 
o Only short term exposure was assesed, making it harder to compare to a real exposure 
scenario. 
o The studies were only performed in vitro hence their weight in assessing risk will be 
smaller compared to in vivo.  
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6 CONCLUSIONS 
In this thesis different mechanisms of importance for carcinogenicity of Ni NPs, NiO NPs 
and NiCl2 were studied, as well as similarities and differences in outcome between these 
exposures. Summary of the conclusions are shown in figure 10. We found: 
o Ni and NiO NPs to induce stronger genotoxic effects compared to NiCl2 and 
identified oxidative stress an important mechanism for genotoxicity rather than direct 
DNA binding. Mutagenicity was in general shown to be low but a significant increase 
could be observed for one dose of NiO NPs (study I). 
 
o Ni and NiO NPs as well as NiCl2 to induce chromosomal damage. A mechanism 
dependent on calcium and iron, but not dependent on cellular uptake was also 
identified (study II) 
 
o Ni and NiO NPs induce release of inflammatory cytokines from exposed 
macrophages. Using a conditioned media approach as well as a co-culture model, 
evidence of secondary genotoxicity was observed, but the factors responsible for the 
results are still unknown (study III).  
 
o Ni and NiO NPs as well as NiCl2 induce EMT markers, cellular invasion/migration, 
stem cell markers as well as decrease in mRNA levels of two tumor suppressor genes 
(study IV). 
 
Figure 10. Concluding overview of the studies.  
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7 FUTURE OUTLOOK 
In this thesis a few of the mechanisms mentioned in Hanahan and Weinberg (2011) was 
investigated i.e. “activating invasion and metastasis” as well as enabling characteristics such 
as “genome instability and mutation” and “tumour promoting inflammation”. It would be of 
interest to investigate effects of Ni and NiO NPs on other cancer mechanisms such as 
“induction of angiogenesis” since we saw an increase of VEGF produced by macrophages in 
study III. Modulation of calcium’s effect on EMT markers after exposure would also be 
interesting to study further since we observed effects on genotoxicity in study II.  
Furthermore it would be of great interest to expand study III. More efforts needs to be taken 
to investigate possible factors causing the secondary genotoxicity observed. The study could 
also be expanded to include more than two cell types. It would be interesting to use primary 
macrophages and differentiate them to different subtypes and investigate differences in 
effects after exposure such as differences in secreted inflammatory factors and effects on 
secondary genotoxicity. I would also be of interest to use more genotoxicity endpoints, than 
the comet assay, such as the micronucleus assy. The same experimental setup could also be 
used to study effects of other NPs than Ni and NiO. Furthermore to connect study III to study 
IV the secreted factors from macrophages effects on EMT in BEAS-2B cells could be 
investigated. 
Secondary genotoxicity is believed to be the main mechanism of genotoxicity noted in vivo 
where cell-cell interplay occurs. Most of the in vitro studies in nanotoxicology are performed 
in 2D and address primary genotoxicity. In study III we used a simple co-culture model to 
study secondary genotoxicity. In the future there is a need to decrease the amount of animal 
experiments used in toxicology hence it is of importance to develop more advanced culture 
systems that better mimic the in vivo scenario. More advanced models such as complex 3D-
cultures and micro tissues should also be considered.   
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